<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76497</article-id><article-id pub-id-type="doi">10.7554/eLife.76497</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Functional requirements for a Samd14-capping protein complex in stress erythropoiesis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-265317"><name><surname>Ray</surname><given-names>Suhita</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0887-6640</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170889"><name><surname>Chee</surname><given-names>Linda</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265371"><name><surname>Zhou</surname><given-names>Yichao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265372"><name><surname>Schaefer</surname><given-names>Meg A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-46961"><name><surname>Naldrett</surname><given-names>Michael J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265370"><name><surname>Alvarez</surname><given-names>Sophie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265373"><name><surname>Woods</surname><given-names>Nicholas T</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-264655"><name><surname>Hewitt</surname><given-names>Kyle J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1946-625X</contrib-id><email>kyle.hewitt@unmc.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00thqtb16</institution-id><institution>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Omaha</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mer456</institution-id><institution>Proteomics and Metabolomics Facility, University of Nebraska-Lincoln</institution></institution-wrap><addr-line><named-content content-type="city">Lincoln</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00thqtb16</institution-id><institution>Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Omaha</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Xu</surname><given-names>Jian</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Banerjee</surname><given-names>Utpal</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>17</day><month>06</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e76497</elocation-id><history><date date-type="received" iso-8601-date="2021-12-17"><day>17</day><month>12</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-06-06"><day>06</day><month>06</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-01-01"><day>01</day><month>01</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.12.31.474625"/></event></pub-history><permissions><copyright-statement>© 2022, Ray et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Ray et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76497-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-76497-figures-v2.pdf"/><abstract><p>Acute anemia induces rapid expansion of erythroid precursors and accelerated differentiation to replenish erythrocytes. Paracrine signals—involving cooperation between stem cell factor (SCF)/Kit signaling and other signaling inputs—are required for the increased erythroid precursor activity in anemia. Our prior work revealed that the sterile alpha motif (SAM) domain 14 (<italic>Samd14</italic>) gene increases the regenerative capacity of the erythroid system in a mouse genetic model and promotes stress-dependent Kit signaling. However, the mechanism underlying Samd14’s role in stress erythropoiesis is unknown. We identified a protein-protein interaction between Samd14 and the α- and β-heterodimers of the F-actin capping protein (CP) complex. Knockdown of the CP β subunit increased erythroid maturation in murine ex vivo cultures and decreased colony forming potential of stress erythroid precursors. In a genetic complementation assay for Samd14 activity, our results revealed that the Samd14-CP interaction is a determinant of erythroid precursor cell levels and function. Samd14-CP promotes SCF/Kit signaling in CD71<sup>med</sup> spleen erythroid precursors. Given the roles of Kit signaling in hematopoiesis and Samd14 in Kit pathway activation, this mechanism may have pathological implications in acute/chronic anemia.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Anemia is a condition in which the body has a shortage of healthy red blood cells to carry enough oxygen to support its organs. A range of factors are known to cause anemia, including traumatic blood loss, toxins or nutritional deficiency. An estimated one-third of all women of reproductive age are anemic, which can cause tiredness, weakness and shortness of breath. Severe anemia drives the release of hormones and growth factors, leading to a rapid regeneration of precursor red blood cells to replenish the supply in the blood.</p><p>To understand how red blood cell regeneration is controlled, Ray et al. studied proteins involved in regenerating blood using mice in which anemia had been induced with chemicals. Previous research had shown that the protein Samd14 is produced at higher quantities in individuals with anemia, and is involved with the recovery of lost red blood cells. However, it is not known how the Samd14 protein plays a role in regenerating blood cells, or whether Samd14 interacts with other proteins required for red blood cell production.</p><p>To shed light on these questions, mouse cells exposed to anemia conditions were used to see what proteins Samd14 binds to. Purifying Samd14 revealed that it interacts with the actin capping protein. This interaction relies on a specific region of Samd14 that is similar to regions in other proteins that bind capping proteins. Ray et al. found that the interaction between Samd14 and the actin capping protein increased the signals needed for the development and survival of new red blood cells.</p><p>These results identify a signaling mechanism that, if disrupted, could cause anemia to develop. They lead to a better understanding of how our bodies recover from anemia, and potential avenues to treat this condition.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Kit</kwd><kwd>stress erythropoiesis</kwd><kwd>erythropoietin</kwd><kwd>Samd14</kwd><kwd>capping protein</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>NHLBI Division of Intramural Research</institution></institution-wrap></funding-source><award-id>R01 HL155439-01</award-id><principal-award-recipient><name><surname>Ray</surname><given-names>Suhita</given-names></name><name><surname>Chee</surname><given-names>Linda</given-names></name><name><surname>Zhou</surname><given-names>Yichao</given-names></name><name><surname>Schaefer</surname><given-names>Meg A</given-names></name><name><surname>Hewitt</surname><given-names>Kyle J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>GMS</institution></institution-wrap></funding-source><award-id>1P20GM121316-01-A1</award-id><principal-award-recipient><name><surname>Hewitt</surname><given-names>Kyle J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Nebraska Stem Cell Research</institution></institution-wrap></funding-source><award-id>LB606</award-id><principal-award-recipient><name><surname>Ray</surname><given-names>Suhita</given-names></name><name><surname>Chee</surname><given-names>Linda</given-names></name><name><surname>Zhou</surname><given-names>Yichao</given-names></name><name><surname>Schaefer</surname><given-names>Meg A</given-names></name><name><surname>Naldrett</surname><given-names>Michael J</given-names></name><name><surname>Alvarez</surname><given-names>Sophie</given-names></name><name><surname>Woods</surname><given-names>Nicholas T</given-names></name><name><surname>Hewitt</surname><given-names>Kyle J</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>K01DK113117-03</award-id><principal-award-recipient><name><surname>Hewitt</surname><given-names>Kyle J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genetic complementation approaches in a mouse model of anemia reveals new protein interactions which aid cell survival and promote sensing of environmental cues.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The expansion and differentiation potential of stem/progenitor cells in the hematopoietic system fluctuates in response to changing environmental conditions. Exposure to toxins, pathogens, blood loss, nutrient deficiency, oxygen deficits, etc. activates transcriptional programs and signal transduction pathways in progenitors and precursors to re-establish homeostasis (<xref ref-type="bibr" rid="bib6">Bresnick et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Socolovsky, 2007</xref>). In acute anemia, vital stress response mechanisms are communicated to erythroid progenitor and precursor cells by secreted factors, including stem cell factor (SCF), erythropoietin (Epo), bone morphogenetic protein (BMP)–4, glucocorticoids, and Hedgehog (<xref ref-type="bibr" rid="bib5">Bauer et al., 1999</xref>; <xref ref-type="bibr" rid="bib31">Lenox et al., 2005</xref>; <xref ref-type="bibr" rid="bib32">Lenox et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Perry et al., 2009</xref>). SCF is the ligand for the Kit receptor tyrosine kinase, which stimulates expansion of cultured erythroid precursors from mouse and human bone marrow via parallel MAPK and PI3K/Akt-signaling pathways (<xref ref-type="bibr" rid="bib30">Lennartsson and Rönnstrand, 2012</xref>; <xref ref-type="bibr" rid="bib35">Munugalavadla and Kapur, 2005</xref>). In vivo, Kit or SCF partial loss-of-function causes chronic anemia and/or acute anemia hypersensitivity (<xref ref-type="bibr" rid="bib7">Broudy et al., 1996</xref>; <xref ref-type="bibr" rid="bib16">Geissler and Russell, 1983</xref>; <xref ref-type="bibr" rid="bib20">Harrison and Russell, 1972</xref>). Mutations that impair Kit signaling are associated with defective stress erythropoiesis and disease pathogenesis (<xref ref-type="bibr" rid="bib2">Agosti et al., 2009</xref>; <xref ref-type="bibr" rid="bib39">Pittoni et al., 2011</xref>). Importantly, context-dependent activation of multiple parallel pathways downstream of Kit are needed to elicit maximal Kit-mediated pro-survival and proliferation signals (<xref ref-type="bibr" rid="bib51">Timokhina et al., 1998</xref>).</p><p>In a mouse model of chemical-induced acute anemia (generated by the erythrocyte lysing agent phenylhydrazine [PHZ]), Sterile Alpha Motif (SAM) domain-containing protein 14 (Samd14) expression increases more than 10-fold in erythroid precursors. Upregulation of Samd14 expression in anemia requires an intronic <italic>cis</italic>-regulatory element (Samd14-Enh) occupied by the transcription factors GATA2 and TAL1 (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>; <xref ref-type="bibr" rid="bib22">Hewitt et al., 2015</xref>). In anemia, Samd14 enhances SCF-mediated Kit signaling (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>). Deletion of Samd14-Enh (<italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic>) does not impact physiological hematopoiesis but causes lethality in a mouse model of severe hemolytic anemia (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>). <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> erythroid precursors exhibit defective regenerative erythropoiesis following PHZ-induced anemia, including formation of fewer erythroid precursor (burst forming unit-erythroid [BFU-E] and colony forming unit-erythroid [CFU-E]) colonies. <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> mice phenocopy the cell signaling deficits and anemia sensitivity seen in the Kit<sup>Y567F/Y567F</sup> knock-in mice (<xref ref-type="bibr" rid="bib2">Agosti et al., 2009</xref>). In both genetic models, deletion/mutation did not perturb physiological erythropoiesis (<xref ref-type="bibr" rid="bib1">Agosti et al., 2004</xref>; <xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>). Given the role of Samd14 in signaling, and similarities between Samd14- and Kit signaling-deficient mice, the mechanism in which Samd14 promotes survival is likely due in part to SCF-mediated activation of Kit signaling.</p><p>While SAMD14 mechanisms are poorly described, several emerging studies have demarcated non-malignant and malignant contexts in which deregulated SAMD14 function may be important. Human variants in the 5’ untranslated region of SAMD14, and polymorphisms attenuating SAMD14 expression, are associated with altered steady state hematologic parameters (<xref ref-type="bibr" rid="bib4">Astle et al., 2016</xref>; <xref ref-type="bibr" rid="bib12">Fehrmann et al., 2011</xref>). SAMD14 promoter hypermethylation and/or downregulation is associated with adenocarcinoma (<xref ref-type="bibr" rid="bib48">Sun et al., 2008</xref>), gastric cancer (<xref ref-type="bibr" rid="bib57">Xu et al., 2020</xref>), and the prostate tumor microenvironment (<xref ref-type="bibr" rid="bib49">Teng et al., 2021</xref>). In an ex vivo genetic complementation assay to restore Samd14 expression in <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> precursors, an evolutionarily conserved SAM domain in SAMD14 functions to increase Kit signal transduction and erythrocyte regeneration (<xref ref-type="bibr" rid="bib41">Ray et al., 2020</xref>). Despite structural similarities, the molecular features of the SAMD14 SAM domain are distinct from SAM domains in other proteins. SAM domains have well-recognized roles in signal transduction, including cell surface receptor activation, receptor endocytosis and MAP kinase activities (<xref ref-type="bibr" rid="bib36">Nagamachi et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Vind et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Wang et al., 2018</xref>). While Samd14 SAM domain contributes to Samd14 activities, the Samd14 protein lacking a SAM domain retains some activities, suggesting additional functional domains. Here, we discovered that SAMD14 interacts with the barbed end actin capping protein (CP) complex via a non-canonical CP-interaction motif to promote erythroid precursor activity and differentiation during stress erythropoiesis. We also provide evidence that, while Samd14 promotes both SCF- and Epo-dependent cell signaling in stress erythroid precursors, the Samd14-CP complex is required for SCF-dependent Kit signaling but not Epo signaling.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The stress-activated Samd14 protein interacts with capping protein complex</title><p>Samd14-enhancer (Samd14–Enh) deletion in mice reduces the regenerative capacity of the erythroid system (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>). In a murine Gata1-null-erythroid (G1E) cell line resembling normal proerythroblasts, we deleted the Samd14-Enh with Transcription Activator-Like Effector Nucleases (TALENs) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib55">Weiss et al., 1997</xref>). Samd14 protein was not detectable in G1E-ΔEnh cells (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). To test whether Samd14 protein interacts with other proteins in proerythroblasts, we infected G1E-ΔEnh cells with GFP-tagged retroviruses expressing empty vector (EV) or hemagglutinin (HA)-Samd14. To normalize levels of exogenous protein that best mimics endogenous levels, infected cells were purified based on a GFP<sup>low</sup> fluorescence-activated cell sorting (FACS) gating strategy (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). GFP was used as a selection marker for this and all subsequent experiments involving retroviral infection. Samd14 interacting proteins were immunoprecipitated (IPed) using anti-HA antibody-conjugated beads and enrichment scores were quantitated by mass spectrometry. We detected 21 proteins which were &gt;twofold enriched in HA-Samd14 pulldown samples vs EV (p&lt;0.05) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Gene ontology analysis revealed enrichment of proteins involved in cell-cell adhesion (6 proteins) and barbed end filamentous (F)-actin filament capping (4 proteins). The most enriched Samd14-interacting proteins (&gt;10-fold) (Capzβ, Capzα1, and Capzα2) belonged to the same family of F-actin CPs, which form a CP complex to regulate actin filament assembly and disassembly (<xref ref-type="bibr" rid="bib25">Isenberg et al., 1980</xref>; <xref ref-type="bibr" rid="bib42">Schafer and Cooper, 1995</xref>). To validate the interaction, we IPed endogenous Samd14 from wild type (WT) G1E cells using an anti-Samd14 antibody. Capzβ co-IPed with Samd14 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). To test whether the Samd14 interaction with Capzβ was SAM domain-dependent, we performed co-IPs in G1E-ΔEnh expressing either EV, HA-Samd14, or HA-Samd14 ΔSAM. No Samd14 or CP complex components were detected in IPs from EV-infected cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). However, Capzβ, Capzα1, and Capzα2 were pulled down in both HA-Samd14- and HA-Samd14 ΔSAM-expressing cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). These results established that Samd14 interacts with CP complex components Capzβ, Capzα1, and Capzα2 in proerythroblasts independent of the SAM domain.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Establishing a Samd14 protein interactome in proerythroblasts.</title><p>(<bold>A</bold>) The mouse sterile alpha motif domain 14 (<italic>Samd14)</italic> locus contains an E-box-GATA composite element (Samd14-Enh sequence highlighted) in intron 1 (<xref ref-type="bibr" rid="bib22">Hewitt et al., 2015</xref>). The G1E wild type (WT) sequence and enhancer knockout G1E-derived cell clone sequence following TALEN directed enhancer knockout (G1E-ΔEnh) are shown. (<bold>B</bold>) Western blot of Samd14 and β-actin expression in G1E, WT clone #4 and G1E-ΔEnh clone. (<bold>C</bold>) Western blot of WT G1E cell lysates following pulldown with anti-Samd14 or anti-rabbit IgG control antibody. Input corresponds to 5% of immunoprecipitation (IP) lysate. (<bold>D</bold>) Western blot of G1E-ΔEnh cell lysates expressing empty vector (EV), hemagglutinin (HA)-Samd14 or HA-Samd14 Δ SAM following anti-HA pulldown. Blots were stained with anti-Samd14, anti-Capzα1, -Capzα2, -Capzβ, and β-actin antibodies. Input corresponds to 5% of IP lysate. (<bold>E</bold>) STRING plot depicting known interactions between capping protein (CP) complex subunits CAPZA1, CAPZA2, and CAPZB (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>). (<bold>F</bold>) Western blot and semi-quantitative densitometry analysis of human CD34<sup>+</sup> cell lysates at 4, 8, 12, 14, and 17 days of differentiation stained with anti-Capzβ and anti-Hsc70 antibodies. (<bold>G</bold>) Quantitation of <italic>Capzb</italic>, <italic>Capza1</italic>, and <italic>Capza2</italic> mRNA transcript levels in fluorescence-activated cell sorting (FACS) purified mouse bone marrow-derived hematopoietic cells. . Data from RNA-sequencing in <xref ref-type="bibr" rid="bib28">Lara-Astiaso et al., 2014</xref>. (<bold>H</bold>) Quantitation of CAPZB, CAPZA1, CAPZA2, and α-adducin (ADD1) protein copies per cell (<xref ref-type="bibr" rid="bib15">Gautier et al., 2016</xref>). Relative levels measured by quantitative mass spectrometry to determine absolute protein levels in human erythroid progenitors throughout differentiation stages. Prog1-Band3<sup>-</sup>CD71<sup>med</sup>GPA<sup>-</sup>, Prog2- Band3<sup>-</sup>CD71<sup>high</sup>GPA<sup>-</sup>, ProE- Band3<sup>-</sup>CD71<sup>high</sup>GPA<sup>low</sup>, Baso1- Band3<sup>low</sup>CD71<sup>high</sup>GPA<sup>med</sup>, Baso2- Band3<sup>med</sup>CD71<sup>high</sup>GPA<sup>high</sup>CD49d<sup>high</sup>, Poly- Band3<sup>med</sup>CD71<sup>high</sup>GPA<sup>high</sup>CD49d<sup>med</sup>, and Ortho-Band3<sup>high</sup>CD71<sup>med</sup>GPA<sup>high</sup>. MEP: megakaryocyte erythroid progenitor; EryA: Ter119<sup>+</sup>CD71<sup>+</sup>FSC<sup>high</sup>; EryB: Ter119<sup>+</sup>CD71<sup>+</sup>FSC<sup>low</sup>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source Western blot images for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-76497-fig1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Expression of Samd14 Interacting proteins in hematopoietic stem/progenitor cells and precursors.</title><p><bold>(A</bold>) Flow cytometry gating strategy to cell sort G1E-ΔEnh cells retrovirally infected with empty vector (EV) and hemagglutinin (HA)-Samd14 for both GFP<sup>low</sup> and GFP<sup>high</sup>. (<bold>B</bold>) Quantitation of <italic>Capzb</italic>, <italic>Capza1</italic>, and <italic>Capza2</italic> transcript levels in fluorescence-activated cell sorting (FACS) purified mouse bone marrow-derived hematopoietic cells. Data mined from RNA-sequencing in <xref ref-type="bibr" rid="bib28">Lara-Astiaso et al., 2014</xref>. LT-HSC: long term-hematopoietic stem cells; HSC: hematopoietic stem cells; MPP: multipotent progenitors; CLP: common lymphoid progenitor; CMP: common myeloid progenitor; GMP: granulocyte monocyte progenitor; MF: macrophage; NK: natural killer cells; MEP: megakaryocyte erythroid progenitor, EryA: Ter119<sup>+</sup>CD71<sup>+</sup>FSC<sup>high</sup>; EryB: Ter119<sup>+</sup>CD71<sup>+</sup>FSC<sup>low</sup>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Role of capping protein complex in erythropoiesis</title><p>In muscle, CP heterodimers (Capzα and Capzβ) are localized to the Z-disk of the sarcomere where they cap barbed end actin filaments (<xref ref-type="bibr" rid="bib10">Casella et al., 1987</xref>; <xref ref-type="bibr" rid="bib46">Solís and Russell, 2019</xref>). CP heterodimers are components of a stable complex containing dynactin, actin-related protein (Arp1) and Arp10 (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) which coordinates a wide range of cellular processes (reviewed in <xref ref-type="bibr" rid="bib43">Schroer, 2004</xref>). <italic>Capzb</italic> expression promotes protein kinase C (PKC)-mediated signal transduction via an interaction between CP and the PKC scaffolding protein Receptor for Activated C-kinase (RACK) (<xref ref-type="bibr" rid="bib40">Pyle et al., 2002</xref>). In mature erythrocytes, while CP is abundantly expressed, CP does not cap actin, but rather is localized to the cytosol unassociated with actin filaments (<xref ref-type="bibr" rid="bib27">Kuhlman and Fowler, 1997</xref>). The expression, localization, and function of CP in early erythroid progenitors and precursors has not been described. To assess CP expression dynamics in erythropoiesis, we differentiated human peripheral blood CD34<sup>+</sup> cells to erythroblasts (<xref ref-type="bibr" rid="bib29">Lee et al., 2015</xref>). In unsorted cells, Capzβ protein levels decreased modestly after 17 days in culture (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Mining RNA-seq data from sorted hematopoietic progenitor cells and progeny from bone marrow (<xref ref-type="bibr" rid="bib28">Lara-Astiaso et al., 2014</xref>) revealed <italic>Capzb</italic>, <italic>Capza1,</italic> and <italic>Capza2</italic> mRNA expression in HSPCs and MEPs decrease following terminal erythroid maturation (<xref ref-type="fig" rid="fig1">Figure 1G</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Quantitative mass spectrometry in FACS-purified human erythroid cells throughout differentiation (<xref ref-type="bibr" rid="bib15">Gautier et al., 2016</xref>) show a gradual decrease in the relative CP protein levels, with the concomitant increase in α-adducin (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). In erythrocytes, α-adducin (ADD1) is a known to promote spectrin-actin assembly, while CP does not appear to interact with actin filaments (<xref ref-type="bibr" rid="bib14">Gardner and Bennett, 1987</xref>; <xref ref-type="bibr" rid="bib27">Kuhlman and Fowler, 1997</xref>).</p><p>To investigate the role of <italic>Capzb</italic> in erythropoiesis, we conducted loss-of-function experiments. Knockdown of <italic>Capzb</italic> in G1E cells by ~80% also lowered expression of the alpha subunit to a similar degree while Samd14 expression remained unchanged (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Lower CP α1/2 expression upon loss of the β subunit is consistent with prior reports (<xref ref-type="bibr" rid="bib44">Sizonenko et al., 1996</xref>). As no prior studies have tested CP function in erythropoiesis, we retrovirally infected E14.5 wildtype mice fetal liver cells with shRNA targeting <italic>Capzb</italic> (sh<italic>Capzb-1 and</italic> sh<italic>Capzb-2</italic>) or a control shRNA targeting the firefly luciferase gene and monitored differentiation by flow cytometry (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). In CD71-expressing cells (R2 and R3), infection with either sh<italic>Capzb-1</italic> or sh<italic>Capzb-2</italic> decreased <italic>Capzb</italic> mRNA by ~ fivefold after 3-day culture (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). To monitor cell maturation through progressive stages of erythroid maturation, 3-day expansion cultures were stained with cell surface markers CD71 and Ter119 (namely R1–R5) (<xref ref-type="bibr" rid="bib59">Zhang et al., 2003</xref>) in control and sh<italic>Capzb</italic>-1 and sh<italic>Capzb-2</italic>-infected cells (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). When quantitated, we observed that <italic>Capzb</italic> knockdown decreased the percentage of less mature R2 (CD71<sup>med/high</sup>Ter119<sup>-</sup>) cells by 2.3-fold (p=0.0013) and R3 (CD71<sup>high</sup>Ter119<sup>+</sup>) cells by 1.5-fold compared to control shRNA-infected cells. <italic>Capzb</italic> knockdown increased the percentages of more mature R4 (2.3-fold, p=0.0035) and R5 (8.4-fold, p=0.0086) erythroid cells (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Capzβ restricts erythroid differentiation during fetal liver hematopoiesis/development.</title><p>(<bold>A</bold>) Western blot of wild type (WT) G1E cell lysates after retroviral infection with control shRNA (sh<italic>Control</italic>) or shRNA targeting <italic>Capzb</italic> mRNA (sh<italic>Capzb2</italic>) stained with anti-sterile alpha motif domain 14 (Samd14), anti-Capzα1, anti-Capzβ, or anti-Hsc70 antibodies. (<bold>B</bold>) Experimental layout. E14.5 mouse fetal liver progenitors are retrovirally infected with sh<italic>Control,</italic> sh<italic>Capzb1,</italic> or sh<italic>Capzb2</italic> and cultured 3 days. R1–R5 flow cytometry gating using anti-CD71 and anti-Ter119 antibodies represents progressive stages of erythroid maturation. (<bold>C</bold>) Quantitation of <italic>Capzb</italic> mRNA in R1 (CD71<sup>low</sup>Ter119<sup>low</sup>), R2 (CD71<sup>high</sup>Ter119<sup>low</sup>), and R3 (CD71<sup>high</sup>Ter119<sup>high</sup>) fetal liver progenitors from WT (N=3) mice in control (sh<italic>Control</italic>) and following <italic>Capzb</italic> knockdown (sh<italic>Capzb1</italic> and sh<italic>Capzb2</italic>). (<bold>D</bold>) Representative flow cytometry of E14.5 fetal liver progenitors expressing shControl<italic>,</italic> sh<italic>Capzb1,</italic> or sh<italic>Capzb2</italic> using anti-CD71 and anti-Ter119 antibodies. (<bold>E</bold>) Quantitation of R1–R5 percentages in E14.5 fetal liver progenitors following retroviral infection with shControl<italic>,</italic> sh<italic>Capzb1,</italic> or sh<italic>Capzb2</italic> and 3-day culture (N=3). Error bars represent SD. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001 (two-tailed unpaired Student’s <italic>t</italic> test).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source Western blot images for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-76497-fig2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig2-v2.tif"/></fig><p>To test whether CP function extends to adult stress erythropoiesis, akin to Samd14, we knocked down <italic>Capzb</italic> in the context of acute anemia induced by PHZ. Stress erythroid progenitors and precursors were isolated from WT spleen, cultured ex vivo, and monitored for erythroid differentiation, erythroid colony forming potential and survival (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="bibr" rid="bib41">Ray et al., 2020</xref>). In contrast to <italic>Samd14</italic>, which increases upon PHZ-induced anemia, <italic>Capzb</italic> and <italic>Capza2</italic> mRNA and protein decreased after PHZ treatment in a population containing erythroid precursors (defined by surface markers CD71<sup>+</sup>Kit<sup>+</sup>Ter119<sup>-</sup>) (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). <italic>Capzb</italic> knockdown in PHZ-treated erythroid precursors decreased <italic>Capzb</italic> expression twofold (p=0.016) and decreased Capzβ protein compared to control infections (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) with no change in Samd14 expression (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). <italic>Capzb</italic> knockdown in spleen erythroid precursors decreased the percentage of early R2/R3 by 2.1-fold and 2.44-fold and increased the percentage of R4/R5 cells by 1.65-fold and 2.35-fold compared to controls (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). In <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> cells, we observed similarly decreased percentages of R2/R3 and increased R4/5 cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Wright-Giemsa staining to assess cell morphology indicated that <italic>Capzb</italic> knockdown cultures contained more mature erythroblasts and reticulocytes than controls (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). <italic>Capzb</italic> knockdown cells were also smaller overall, as measured by the decreased forward scatter-area of the cells in R2–R5 populations, consistent with increased numbers of mature cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). These data demonstrate that <italic>Capzb</italic> expression opposes erythroid maturation in developing fetal liver progenitors and in splenic stress erythroid precursors. <italic>Capzb</italic> knockdown data are comparable to previously published data in which <italic>Samd14</italic> knockdown decreased R2/R3 percentages and increased R4/5 percentages in erythroid cultures (<xref ref-type="bibr" rid="bib22">Hewitt et al., 2015</xref>), suggesting that Samd14 and Capzβ may have similar roles in erythropoiesis.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Capping protein (CP) complex promotes stress progenitor activity.</title><p>(<bold>A</bold>) Experimental layout of ex vivo spleen retroviral infection and cultures. (<bold>B</bold>) Relative mRNA expression of sterile alpha motif domain 14 (<italic>Samd14)</italic>, <italic>Capzb, Capza1</italic>, and <italic>Capza2</italic> in control vs phenylhydrazine (PHZ)-treated CD71<sup>+</sup>Kit<sup>+</sup>Ter119<sup>-</sup> spleen cultures. (<bold>C</bold>) Quantitation of <italic>Capzb</italic> mRNA in fluorescence-activated cell sorting (FACS)-purified GFP<sup>+</sup>Kit<sup>+</sup>CD71<sup>+</sup> cells from wild type (WT) mice following retroviral infection with shControl<italic>,</italic> sh<italic>Capzb2</italic> after 2-day culture (left); Western blot of primary spleen cultures following Capzβ knockdown (sh<italic>Capzb2</italic>) or sh<italic>Control</italic> stained with anti-Capzβ and β-actin antibodies (right). (<bold>D</bold>) Quantitation of <italic>Samd14</italic> mRNA in FACS-purified GFP<sup>+</sup>Kit<sup>+</sup>CD71<sup>+</sup> cells from WT mice following retroviral infection with shControl<italic>,</italic> sh<italic>Capzb2</italic> after 2-day culture. (<bold>E</bold>) Quantitation of infected R1–R5 cells in WT PHZ-treated cells following <italic>Capzb</italic> knockdown. (<bold>F</bold>) Representative images from Wright-Giemsa stained cells following Capzb knockdown (40 × magnification)(<bold>G</bold>) Retrovirally-infected spleen progenitors were GFP-purified by FACS and grown for 2 days colony forming unit-erythroid (CFU-E) or 5 days burst forming unit-erythroid (BFU-E) and quantitated (N=9). (<bold>H</bold>) Representative flow cytometry scatter plot of membrane-impermeable DNA dye (Draq7) and anti-annexin V pacific blue (AnnV). Cells were first segregated on GFP<sup>+</sup> and Kit<sup>+</sup> gating. Live = Draq7<sup>−</sup> AnnV<sup>−</sup>; Early apoptotic (EA)=Draq7<sup>−</sup>AnnV<sup>+</sup>; Late apoptotic (LA)=Draq7<sup>+</sup>AnnV<sup>+</sup>. (<bold>I</bold>) Quantitation of percent dead, LA and EA cells in the GFP<sup>+</sup>Kit<sup>+</sup> cells (left) and GFP<sup>+</sup>CD71<sup>+</sup>Ter119<sup>+</sup> (right). Error bars represent SD. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001 (two-tailed unpaired Student’s <italic>t</italic> test).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source Western blot images for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-76497-fig3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>CP complex function in erythropoiesis.</title><p><bold>(A</bold>) Relative mRNA expression of <italic>Capzb, Capza1</italic>, and <italic>Capza2</italic> in control vs phenylhydrazine (PHZ)-treated spleen. (<bold>B</bold>) Western blot of control vs PHZ-treated spleens stained with anti-Capzβ and β-actin antibodies (left). Densitometry analysis of relative Capzβ expression in control vs PHZ-treated spleens (N=4) (right). (<bold>C</bold>) Quantitation of infected R1–R5 cells in sterile alpha motif domain 14-enhancer (Samd14-Enh<sup>-/-</sup>)PHZ-treated cells following <italic>Capzb</italic> knockdown (N=9). (<bold>D</bold>) Representative histogram of forward scatter area (FSC-A) in R2–R5 cells following sh<italic>Zb2</italic> knockdown or sh<italic>Control</italic> (left); Quantitation of median FSC-A in sh<italic>Capzb2</italic> vs sh<italic>Control</italic> (N=5) (right). (<bold>E</bold>) Quantitation of colony forming unit-erythroid (CFU-E) colonies in spleen precursors following <italic>Capzb</italic> knockdown (N=6). (<bold>F</bold>) Quantitation of percent dead (Draq7<sup>+</sup>) infected R1–R5 cells in wild type (WT) PHZ-treated spleen cells following <italic>Capzb</italic> knockdown (N=4). (<bold>G</bold>) Quantitation of percent dead (DAPI<sup>+</sup>) in infected R1–R5 cells in untreated WT Lin<sup>-</sup> bone marrow cells following <italic>Capzb</italic> knockdown (N=4). (<bold>H</bold>) Quantitation of the percent of Ki67<sup>+</sup> cells within CD71<sup>low/med</sup>Kit<sup>+</sup> population following <italic>Capzb</italic> knockdown (N=4). Error bars represent SD. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001 (two-tailed unpaired Student’s <italic>t</italic> test).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Source Western blot images for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-76497-fig3-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To determine whether CP complex regulates erythroid precursor activity, we performed colony forming unit (CFU) assays in cells infected with control or sh<italic>Capzb2. Capzb</italic> knockdown cells were plated in methylcellulose semisolid media containing SCF and Epo to promote BFU-E and CFU-E activity. Compared to controls, <italic>Capzb</italic> knockdown cells formed 1.5-fold fewer BFU-E (p=0.016) and threefold fewer CFU-E (<xref ref-type="fig" rid="fig3">Figure 3G</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>) colonies. Prior work indicated that <italic>Capzb</italic> depletion increased cell proliferation (<xref ref-type="bibr" rid="bib3">Aragona et al., 2013</xref>). We quantitated proliferating erythroid precursor cells using Ki67 in CD71<sup>low</sup>Kit<sup>+</sup>. The percentage of Ki67<sup>+</sup> cells were 1.6-fold higher in Capzb-depleted cells compared to controls (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). To test whether <italic>Capzb</italic> promotes cellular viability and survival, we analyzed cultured spleen progenitors by flow cytometry for percentages of live (AnnexinV<sup>−</sup>Draq7<sup>−</sup>), early apoptotic (EA; AnnexinV<sup>+</sup>Draq7<sup>−</sup>), and late apoptotic cells (LA; AnnexinV<sup>+</sup>Draq7<sup>+</sup>) cells. In Capzb knockdown cells vs controls, the percentages of dead cells (Draq7<sup>+</sup>) in spleen and bone marrow cultures were higher throughout immunophenotypically defined stages of erythroid maturation (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and F</xref>). Correspondingly, EA (AnnexinV<sup>+</sup>Draq7<sup>-</sup>) and LA (AnnexinV<sup>+</sup>Draq7<sup>+</sup>) cells increased in <italic>Capzb</italic> knockdown cells vs control knockdown (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). <italic>Capzb</italic> knockdown increased the percentage of late apoptotic cells 2.8-fold in GFP<sup>+</sup>Kit<sup>+</sup> and 3.68-fold in GFP<sup>+</sup>CD71<sup>+</sup>Ter119<sup>+</sup> compared to control (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). The CP complex therefore promotes erythroid precursor activity and survival following acute anemia.</p></sec><sec id="s2-3"><title>A non-canonical CP binding domain facilitates Samd14-CP complex formation and function</title><p>As a first step to establishing whether Samd14 and CP complex form a cooperative functional unit to regulate erythropoiesis in anemia, we identified candidate Samd14 sequences which may mediate capping protein binding (CPB). Since the Samd14-CP interaction occurs independent of the SAM domain (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), we generated a series of Samd14 truncation mutants outside the SAM domain that corresponded with proteins known to interact with CP (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Amino acids 38–54 of Samd14 share 3 out of 7 consensus sequence residues (43%) with the CP interaction (CPI) motif LXHXTXXRPK(6×)P (X=any amino acid) (<xref ref-type="bibr" rid="bib8">Bruck et al., 2006</xref>; <xref ref-type="bibr" rid="bib11">Edwards et al., 2015</xref>), present in CPI proteins CP, ARP2/3 and Myosin I Linker (CARMIL), CD2-associated protein (CD2AP), Cin85, CapZ interacting protein (CapZIP), CK2-interacting protein 1 (CKIP-1); also known as PLEKHO1 (<xref ref-type="bibr" rid="bib9">Canton et al., 2006</xref>). A proline-rich region of Samd14 (a.a. 114–124) aligned with five amino acids in the CPI protein Neurabin-1. Two additional proline rich regions of Samd14 aligning with CKIP-1 at residues 170–180 and 272 and 295, but not predicted to interact with CP, were deleted as controls. HA-tagged truncation constructs lacking these regions (Samd14-∆38–54, Samd14-∆114–124, Samd14-∆170–180, Samd14-∆272–295) were expressed in G1E-∆Enh cells at similar levels (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). GFP<sup>low</sup> cells were FACS purified at 48 hr post-infection and Samd14-∆38–54, Samd14-∆114–124, Samd14-∆170–180, and Samd14-∆272–295 proteins were IPed using anti-HA agarose beads. When we analyzed IP proteins by Western blotting, Samd14-∆37–55 failed to pull down Capzβ and Capzα2 in contrast to three other Samd14 deletion constructs (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Thus, amino acids 37–55 of Samd14 mediate the Samd14-CP interaction. Since this interaction domain has a low degree of sequence conformity with the canonical CPI motif, we refer to it as the Samd14 CPB domain.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Capping protein binding (CPB) domain of sterile alpha motif domain 14 (Samd14) promotes stress progenitor activity.</title><p>(<bold>A</bold>) Schematic representation of Samd14 deletion construct location, protein sequence, and sequence alignment with known capping protein interacting (CPI) proteins. (<bold>B</bold>) Western blot of G1E-ΔEnh cell lysates expressing empty vectore (EV) or hemagglutinin (HA)-tagged Samd14, Samd14- Δ38–54, Samd14-Δ114–124, Samd14-Δ170–180, or Samd14-Δ272–295 constructs immunoprecipitation (IP) with anti-HA beads and stained with anti-HA, anti-Capzβ, anti-Capzα2, anti-Capzα1, or anti-β-actin antibodies. (<bold>C</bold>) Western blot of Lin- WT phenylhydrazine (PHZ)-treated spleen lysates immunoprecipitated (IPed) with anti-Samd14 or anti-rabbit IgG antibodies and stained with anti-Samd14 or anti-Capzβ antibodies. (<bold>D</bold>) Quantitation of colony forming unit-erythroid (CFU-E) (day 2 culture) and burst forming unit-erythroid (BFU-E) (day 5 culture) colonies in GFP<sup>+</sup> spleen progenitors expressing EV, HA-tagged Samd14, Samd14 ΔSAM, Samd14 ΔCPB, and Samd14 ΔCPBΔSAM constructs (N=6). Error bars represent SD. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001 (two-tailed unpaired Student’s <italic>t</italic> test).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source Western blot images for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-76497-fig4-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Dynamic regulation of Samd14-CP interaction in PHZ-induced anemia.</title><p><bold>(A</bold>) Western blot of Lin<sup>-</sup> wild type (WT) spleen lysates obtained from mice treated with either PBS (control) or phenylhydrazine (PHZ) (100 mg/kg) immunoprecipitated (IPed) with anti-sterile alpha motif domain 14 (Samd14) or anti-rabbit IgG antibodies and stained with anti-Samd14, or anti-Capzβ antibodies (left). Densitometry analysis of the relative CapZβ co-IPed with Samd14 in PBS (control) vs PHZ (right). (<bold>B</bold>) Western blot of R2 (CD71<sup>+</sup>Ter119<sup>-</sup>) and R3 (CD71<sup>+</sup>Ter119<sup>+</sup>) cells sorted from WT PHZ-treated spleen lysates IPed with anti-Samd14 or anti-rabbit IgG antibodies and stained with anti-Samd14 or anti-Capzβ antibodies. (<bold>C</bold>) Western blot of Lin-WT PHZ-treated spleen cells treated with +/-stem cell factor (SCF) (10 ng/ml) for 5 min and IPed with anti-Samd14 or anti-rabbit IgG antibodies and stained with anti-Samd14 or anti-Capzβ antibodies (left). Densitometry analysis of the relative CapZ co-IPed with Samd14 in the presence or absence of SCF (right).</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source Western blot images for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-76497-fig4-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig4-figsupp1-v2.tif"/></fig></fig-group><p>In lineage-depleted spleen cells 3 days after PHZ injection, we confirmed by co-IP that the Samd14-CP interaction occurs in endogenously expressed proteins (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). To determine if the Samd14-CP complex was dynamically regulated in anemia, we compared co-IP in control spleen to spleen isolated from PHZ-treated mice. In PHZ-treated spleen, more Capzb protein was pulled down compared to control spleen (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), indicating that the frequency and/or stability of the Samd14-CP interaction was increased in acute anemia. No differences were seen in the amount of Capzb pulled down in CD71<sup>+</sup>Ter119<sup>-</sup> vs CD71<sup>+</sup>Ter119<sup>+</sup> cells, or in response to acute SCF stimulation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B and C</xref>). Therefore, Samd14-CP complex formation was not stage- or signal-dependent.</p><p>We previously described a SAM domain requirement for Samd14-mediated erythroid progenitor activity in PHZ-induced stress erythroid progenitors. To determine if the Samd14 CPB domain promotes unique Samd14 functions, or whether SAM and CPB domains act synergistically, we utilized an ex vivo genetic complementation assay in which Samd14 is exogenously expressed in <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> PHZ-treated spleen erythroid progenitor cells. Primary cells infected with either full length Samd14, Samd14 lacking the SAM domain (S14-∆SAM), CPB domain (S14-∆CPB), or both (S14-∆SAM∆CPB) were sorted based on GFP expression and plated in methylcellulose semisolid media for colony assays. Whereas Samd14 promoted BFU-E activity vs empty vector, S14-∆SAM and S14-∆CPB had fewer BFU-E colonies compared to Samd14 (1.5-fold and 1.6-fold, respectively) (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). In S14-∆SAM∆CPB-infected cells, BFU-E activity was 2.2-fold lower than Samd14 (p&lt;0.0001). BFU-E in S14-∆SAM∆CPB-infected cells were decreased by 1.4-fold (p=0.009) vs S14-∆SAM, suggesting a synergistic role of both domains to promote Samd14 activity in stress BFU-E (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Consistent with prior results demonstrating that the SAM domain is not needed for CFU-E colony formation, we observed similar decreases in numbers of CFU-E in S14-∆CPB (1.5-fold, p=0.0048) and S14-∆SAM∆CPB (1.7-fold) expressing cells vs full length Samd14.</p><p>Given the role of Samd14 in stress-activated SCF/Kit signaling (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Ray et al., 2020</xref>), we tested whether the Samd14 CPB mediates SCF-dependent activation of cell signaling in stress erythroid cultures. 48 hr after infection with either control (EV) or HA-Samd14 retrovirus, lineage-depleted splenocytes from PHZ-treated <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> mice were serum-starved, stimulated with SCF, and analyzed by flow cytometry for AKT and ERK activation. The cell surface marker CD71 (transferrin receptor) can be used to distinguish among stages of erythroid differentiation (<xref ref-type="bibr" rid="bib13">Flygare et al., 2011</xref>). As each cell stage has distinct cell signaling requirements, we sub-divided GFP<sup>+</sup> cells into CD71<sup>low</sup>, CD71<sup>med</sup>, and CD71<sup>high</sup> fractions, and then gated for Kit expressing cells by flow cytometry (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). CD71<sup>low</sup> cells contained BFU-Es and very few cells expressing the mature erythroid marker Ter119<sup>+</sup>, which increased in frequency in CD71<sup>med</sup> and CD71<sup>high</sup> cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). As prior studies indicated, there is a continuum of cell phenotypes from CD71<sup>low</sup>Kit<sup>+</sup>, CD71<sup>med</sup>Kit<sup>+</sup> to CD71<sup>high</sup>Kit<sup>+</sup> characterized by a transition from BFU-E to CFU-E, distinct proliferative indices, and transcriptional states (<xref ref-type="bibr" rid="bib33">Li et al., 2019</xref>). CD71<sup>med</sup>Kit<sup>+</sup> cells contained more cells with CFU-E potential compared to CD71<sup>high</sup>Kit<sup>+</sup> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B and C</xref>). Samd14 expression increased the percentage of CD71<sup>low</sup> Kit<sup>+</sup> (1.35-fold) and CD71<sup>med</sup>Kit<sup>+</sup> (1.5-fold) cells (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). In EV-infected <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic>, the median fluorescence intensity (MFI) of CD71<sup>low</sup>Kit<sup>+</sup> cells stained with phospho-ERK (pERK) or phospho-AKT (pAKT) antibodies increased by 62.7-fold and 65.3-fold, respectively, after SCF stimulation. Samd14 expression did not alter pAKT or pERK MFI in CD71<sup>low</sup>Kit<sup>+</sup> cells (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>). Consistent with this, pERK levels were similar between EV-infected WT and <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> cells, indicating that Kit signaling in the CD71<sup>low</sup> population is insensitive to Samd14 expression (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). In CD71<sup>med</sup> cells, pERK levels were 4.3-fold (p&lt;0.0001) lower in EV-infected <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> cells compared to WT EV-infected cells, indicating that CD71<sup>med</sup> cells are sensitive to Samd14 expression levels (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). pERK MFI in <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> CD71<sup>med</sup> cells was rescued by Samd14 (<xref ref-type="fig" rid="fig5">Figure 5B and D</xref>). Samd14 expression increased the levels of pERK (4.4-fold) and pAKT (15.3-fold) in SCF-treated CD71<sup>med</sup> cells compared to EV controls (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). In CD71<sup>high</sup> cells, pAKT and pERK levels in Kit<sup>+</sup> cells do not change after SCF stimulation. However, pAKT and pERK levels in CD71<sup>high</sup>Kit<sup>+</sup> cells are sensitive to Samd14 expression (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). These results indicated that distinct Kit<sup>+</sup> populations gated on CD71 show varying signaling response (as measured by pAKT and pERK) to SCF and Samd14, but do not distinguish whether Kit<sup>+</sup> cells in the CD71<sup>+</sup> gates are completely unresponsive to SCF stimulation or whether Kit signaling is occurring via other pathways. Finally, we tested whether the SAM or CPB domains of Samd14 could alter Samd14 sensitivity in the SCF-responsive CD71<sup>med</sup>Kit<sup>+</sup> cells. Deleting either the SAM or the CPB domain of Samd14 reduced levels of pAKT (fourfold) and pERK (twofold) compared to Samd14 in the CD71<sup>med</sup> population (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). As an alternative assessment of Kit signal-promoting roles of the Samd14 CPB domain, we examined the activation of Kit transcription in response to SCF stimulation (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). Whereas Kit transcript levels were significantly increased in Samd14-expressing cells vs controls, we did not detect significant increases in Kit transcript levels in S14-ΔCBP expressing cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). Both the SAM and CPB domains of Samd14 are required for maximal promotion of Kit signaling in stress erythroid precursors.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Sterile alpha motif domain 14 (Samd14)-capping protein (CP) enhances stem cell factor (SCF)/Kit signaling in CD71<sup>med</sup> stress progenitors.</title><p>(<bold>A</bold>) Flow cytometry gating to analyze retrovirally infected (GFP<sup>+</sup>) cells based CD71<sup>low</sup>, CD71<sup>med</sup> and CD71<sup>high</sup>, and Kit<sup>+</sup> (left); Percent GFP<sup>+</sup>CD71<sup>+</sup>Kit<sup>+</sup> cells in CD71<sup>low</sup>, CD71<sup>med</sup>, and CD71<sup>high</sup> fractions in phenylhydrazine (PHZ)-treated spleens expressing empty vector (EV) or hemagglutinin (HA)-Samd14 (N=9) (right). (<bold>B</bold>) Histograms depicting pAKT fluorescence in GFP<sup>+</sup>CD71<sup>low</sup>Kit<sup>+</sup>, GFP<sup>+</sup>CD71<sup>med</sup>Kit<sup>+</sup>, and GFP<sup>+</sup>CD71<sup>high</sup>Kit<sup>+</sup> erythroid precursors in unstimulated (dotted line) or post-SCF stimulation (5 min, 10 ng/ml) (solid line). (<bold>C</bold>) Quantitation of pERK1/2 (left) and pAKT (right) median fluorescence intensity (MFI) in GFP<sup>+</sup>CD71<sup>low</sup>Kit<sup>+</sup> cells from wild type (WT) or Samd14- <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> spleen expressing EV or HA-Samd14 at 5 min post-SCF stimulation. (<bold>D</bold>) Quantitation of pERK1/2 (left) and pAKT (right) MFI in GFP<sup>+</sup>CD71<sup>med</sup>Kit<sup>+</sup> cells from WT or <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> spleen expressing EV or HA-Samd14 at 5 min post-SCF stimulation. (<bold>E</bold>) Quantitation of pERK1/2 (left) and pAKT (right) MFI in GFP<sup>+</sup>CD71<sup>high</sup>Kit<sup>+</sup> cells from WT or <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> spleen expressing EV or HA-Samd14 at 5 min post-SCF stimulation. (<bold>F</bold>) Quantitation of pERK1/2 and pAKT MFI in GFP<sup>+</sup>CD71<sup>med</sup>Kit<sup>+</sup> retrovirally infected spleen cells with EV, HA-tagged Samd14, Samd14 ΔSAM, Samd14 ΔCPB and Samd14 ΔCPBΔSAM (N=6). Error bars represent SD. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001 (two-tailed unpaired Student’s <italic>t</italic> test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Linking progenitor activity and transcriptional activation in immunophenotypically defined populations.</title><p><bold>(A</bold>) Quantitation of the percent of Ter119<sup>+</sup> cells within CD71<sup>low</sup> Kit<sup>+</sup>, CD71<sup>med</sup>Kit<sup>+</sup>, and CD71<sup>high</sup>Kit<sup>+</sup> populations from wild type (WT)-phenylhydrazine (PHZ)-treated spleen cells after 48 hr of culture (N=3). (<bold>B</bold>) Representative images for burst forming unit-erythroid (BFU-E) and colony forming unit-monocyte/macrophage (CFU-M) colonies formed (day 5 after plating) from CD71<sup>low</sup> Kit<sup>+</sup> cells, and colony forming unit-erythroid (CFU-E) colonies formed (day 2 after plating) from CD71<sup>med</sup>Kit<sup>+</sup> and CD71<sup>high</sup>Kit<sup>+</sup> cells. (<bold>C</bold>) Quantitation of CFU-E (day 2 after plating) colonies from CD71<sup>med</sup>Kit<sup>+</sup> and CD71<sup>high</sup>Kit<sup>+</sup> cells sorted from WT-PHZ-treated spleen cells after 48 hr of culture (N=9). (<bold>D</bold>) Experimental layout of gene expression analysis on ex vivo PHZ treated Samd14-Enh-/- spleen post-SCF stimulation (1h, 10ng/ml). (<bold>E</bold>) Quantitation of relative Kit primary transcript levels in the presence and absence of SCF (1h, 10ng/ml) in PHZ-treated Samd14-Enh-/- spleen infected with EV, HA-tagged Samd14, and Samd14 ΔCPB (N=3).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig5-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Structural and functional requirements of the Samd14 CPB domain</title><p>The Samd14 CPB sequence, which is required for SCF/Kit signaling and Samd14-dependent erythroid precursor activities, is conserved in amphibians, reptiles, birds, and mammals (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). When we aligned functionally-validated CPI domains identified in CPI proteins Twinfilin (Twf1) (<xref ref-type="bibr" rid="bib26">Johnston et al., 2018</xref>), CapZIP, WASHCAP (<xref ref-type="bibr" rid="bib21">Hernandez-Valladares et al., 2010</xref>), CKIP-1 (<xref ref-type="bibr" rid="bib9">Canton et al., 2006</xref>), CARMIL1 (<xref ref-type="bibr" rid="bib58">Yang et al., 2005</xref>), CIN85, and CD2AP (<xref ref-type="bibr" rid="bib8">Bruck et al., 2006</xref>), each contain a central arginine (R) or lysine (K) containing R/KXR/K motif (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Given the low sequence identity between Samd14 CPB and the other identified CPI motifs, we conducted a proteome-wide search for similar peptide sequences. The Samd14 CPB aligned to a region of Neurabin-1 (64.7% sequence identity) (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Interestingly, Neurabin-1 also contains a SAM domain. In functional studies of CPI domains, central arginine residues are required to mediate CP complex interaction (<xref ref-type="bibr" rid="bib26">Johnston et al., 2018</xref>). To determine if the aligned arginine residues in the Samd14 CPB domain mediate CP complex binding we mutated the R43/R45 to alanine (Samd14-R43/45 A) in an expression construct (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). To test whether the Samd14-CPB domain function could be replaced by known CPI domains in other proteins, we substituted 17-amino acids in the Samd14-CPB domain with another known CPI motif in CKIP-1 (23.5% protein sequence identity, maintaining central arginine residues). We performed an IP Western blot of HA-tagged Samd14-R43/45 A and the Samd14-Ckip1 CPI proteins expressed in G1E-∆Enh cells. GFP<sup>high</sup> and GFP<sup>low</sup> FACS sorted cells were prepared and analyzed separately to assess whether high/low expression levels of exogenous protein may alter binding affinity (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Surprisingly, the Samd14-Ckip1 CPI chimeric protein failed to pull down any CP complex subunits (Capzβ, Capzα1, and Capzα2) (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Whereas Samd14-R43/45 A still interacts with the CP complex, the mutation reduced the amount of CP complex components pulled down (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). Thus, Samd14 R43/45 residues mediate CPB affinity but are not required. Next, we tested whether expression of Samd14-Ckip1 CPI or Samd14-R43/45 A (which interfere with Samd14 binding to CP) impairs Samd14 function. PHZ-treated <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> spleen progenitors expressing Samd14-Ckip1 CPI formed 2.23-fold and 1.5-fold fewer BFU-E and CFU-E than Samd14, respectively (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). However, cells expressing Samd14-Ckip1 CPI and Samd14-∆CPB formed similar numbers of colonies (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). The Samd14-R43/45A-expressing cells (with reduced but not absent CPB) formed fewer BFU-E and CFU-E colonies compared to Samd14 but more than Samd14-∆CPB (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). These results demonstrate the importance of the Samd14-CP interaction for Samd14-mediated stress erythroid precursor activity. Compared to other functionally validated CPB domains, the Samd14 CPB domain has additional sequence attributes that enable the Samd14-CP protein interaction.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Atypical capping protein interaction (CPI) domain of sterile alpha motif domain 14 (Samd14) conferring stress erythroid precursor activity.</title><p>(<bold>A</bold>) Sequence alignment of the capping protein binding (CPB) domain of Samd14 among vertebrate species. Aligned using Clustal Omega and visualized with JalView. Yellow bars in conservation plot represents evolutionary conservation. (<bold>B</bold>) Sequence alignment of the capping protein interaction (CPI) motif in other proteins with Samd14 CPB domain. Yellow color indicates conserved residues among the different CPI motifs. (<bold>C</bold>) Schematic representation of chimeric and mutated CPB domain Samd14 constructs. (<bold>D</bold>) Western blot of GFP-sorted G1E-ΔEnh cells expressing empty vector (EV), hemagglutinin (HA)-Samd14, Samd14-∆CPB, Samd14(S14)-Ckip1-CPI, or Samd14-R43/45 A stained with anti-HA. HA and β-actin (<bold>E</bold>) Western blot analysis of Capzα1, Capzα2, and Capzβ co-immunoprecipitated (IPed) following pull-down of EV, HA-tagged Samd14, Samd14-∆CPB, Samd14(S14)-Ckip1-CPI and Samd14-R43/45 A with anti-HA agarose beads from retrovirally infected G1E-ΔEnh cells. (<bold>F</bold>) Densitometry analysis of the relative CapZ co-IPed with either HA-Samd14 or HA-S14-R43/45 R. (<bold>G</bold>) Quantitation of GFP<sup>+</sup> colony forming unit-erythroid (CFU-E) (N=9) and burst forming unit-erythroid (BFU-E) (N=17) colonies formed in spleen progenitors retrovirally infected with EV, HA-tagged Samd14, Samd14-∆CPB, Samd14(S14)-Ckip1-CPI, and Samd14-R43/45 A. Error bars represent SD. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001 (two-tailed unpaired Student’s <italic>t</italic> test).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source Western blot images for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-76497-fig6-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig6-v2.tif"/></fig><p>Given that Samd14 promoted SCF signaling within a narrow window of CD71 expression, it is possible that Samd14 regulates other signaling pathways at distinct stages of erythropoiesis. Erythropoietin signaling regulates erythroid maturation and cell survival during stress as well as normal erythropoiesis (<xref ref-type="bibr" rid="bib34">Liu et al., 2006</xref>; <xref ref-type="bibr" rid="bib56">Xiang et al., 2015</xref>). To test whether Samd14 regulates Epo signaling, we serum starved and Epo stimulated cultures expressing either EV, Samd14, or Samd14-∆CPB and assessed AKT activation. pAKT increased 2.28-fold (p=0.0002) in Samd14-expressing cells vs EV control (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Similarly, pERK increased 5.85-fold in Samd14 expressing cells vs EV controls (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Surprisingly the Samd14-∆CPB also increased the pAKT levels by 2.3-fold (p=0.0002). This contrasts with our results in SCF stimulated cells, suggesting that the Samd14-CP interaction drives Samd14-dependent Kit signaling but is dispensable for Epo signaling (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). To test the involvement of <italic>Capzb</italic> in cell signaling, we analyzed ERK1/2 activation levels upon SCF/Epo stimulation after <italic>Capzb</italic> knockdown. SCF responsive cells (CD71<sup>low</sup>, CD71<sup>med</sup>, <xref ref-type="fig" rid="fig5">Figure 5B</xref>) were analyzed together as GFP<sup>+</sup>CD71<sup>low/med</sup>Kit<sup>+</sup> cells (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). <italic>Capzb</italic> knockdown decreased SCF-dependent pERK1/2 activation by 19.3-fold (p=0.001) relative to sh<italic>Control</italic> (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) and reduced the overall magnitude (MFI) of SCF-mediated pERK1/2 activation (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). Following Epo stimulation, the CD71<sup>high</sup> fraction (which is unresponsive to SCF) increased ERK1/2 phosphorylation (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Epo-stimulated pERK1/2 was unaffected by <italic>Capzb</italic> knockdown in CD71<sup>high</sup> cells. A similar trend was seen using pAKT as a readout for Epo signaling (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>). These data define cell stage-specific requirements for Samd14 in both SCF/Kit and Epo/EpoR signaling pathways (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Whereas <italic>Capzb</italic> expression and the CPB domain of Samd14 promote Kit signaling, the interaction between Samd14 and CP is not an important mediator of Epo signaling (<xref ref-type="fig" rid="fig7">Figure 7E</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Sterile alpha motif domain 14 (Samd14) increases erythropoietin (Epo) signaling independent of capping protein (CP) complex interaction.</title><p>(<bold>A</bold>) Quantitation of pAKT MFI in GFP<sup>+</sup>CD71<sup>high</sup>Ter119<sup>+</sup> retrovirally infected <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> spleen cells expressing empty vector (EV), hemagglutinin (HA)-Samd14 or Samd14-∆CPB at 10 min post-Epo (5 U/ml) stimulation (N=7). (<bold>B</bold>) Flow cytometry gating to analyze infected (GFP<sup>+</sup>) phenylhydrazine (PHZ)-treated cells expressing sh<italic>Control</italic> or sh<italic>Capzb2</italic> based on CD71<sup>low/med</sup> and CD71<sup>high</sup>; representative histograms depict pERK1/2 fluorescence in GFP<sup>+</sup>CD71<sup>low/med</sup>Kit<sup>+</sup> cells after stem cell factor (SCF) stimulation (10 ng/ml, 5 min) and GFP<sup>+</sup>CD71<sup>high</sup> cells after Epo stimulation (10 min, 5 U/ml). (<bold>C</bold>) Quantitation of pERK1/2 MFI after SCF (5 min, 10 ng/ml) or Epo (10 min, 5 U/ml) stimulation in GFP<sup>+</sup>CD71<sup>+</sup>Kit<sup>+</sup> and GFP<sup>+</sup>CD71<sup>high</sup> spleen cells expressing sh<italic>Control</italic> or sh<italic>Capzb2</italic> (N=3). (<bold>D</bold>) CD71<sup>low</sup> cells are SCF-responsive but Samd14-insensitive, CD71<sup>med</sup> are SCF-responsive and Samd14-sensitive, and CD71<sup>high</sup> cells are unresponsive to SCF. CD71<sup>low/med</sup> cells responding to SCF do not respond to Epo stimulation, whereas the CD71<sup>high</sup> cells are Epo dependent and Samd14-sensitive. (<bold>E</bold>) Samd14-CP interaction promotes burst forming unit-erythroid (BFU-E) colony formation, SCF/Kit and Epo/EpoR signaling by phosphorylating ERK1/2 and AKT in PHZ-treated spleen cells, in the absence of the Samd14-CP interaction PHZ-treated spleen cells fails to promote SCF/Kit signaling, but Epo signaling remains unaffected. Error bars represent SD. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001 (two-tailed unpaired Student’s <italic>t</italic> test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Samd14-CP enhances SCF/Kit signaling.</title><p>(<bold>A</bold>) Quantitation of pERK median fluorescence intensity (MFI) in GFP+CD71highTer119+ retrovirally infected Samd14-(deltasymbolEnh/DeltasymbolEnh) spleen cells with either EV or HA-Samd14 at 10 min post-erythropoietin (Epo) (5 U/ml) stimulation (N=3). (<bold>B</bold>) Quantitation of pERK median fluorescence intensityMFI on SCF (5 mins, 10 ng/ml) in GFP+CD71low/medKit+ retrovirally infected wild type (WT) spleen cells with shControl or shZb2 (N=3). (<bold>C</bold>) Quantitation of pAKT MFI on SCF (5 mins, 10 ng/ml) or Epo (10 mins, 5 U/ml) stimulation in GFP+CD71low/medKit+ and GFP+CD71high retrovirally infected WT spleen cells with shControl or shCapzb2 (N=3). Error bars represent the standard deviation (SD). *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001 (two-tailed unpaired Student’s t test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76497-fig7-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>To reveal mechanisms of anemia stress-activated protein Samd14, and its function in cell signaling, we analyzed Samd14-interacting proteins. We report that Samd14 interacted with a family of F-actin CPs (Capzβ, Capzα1, and Capzα2) in a SAM domain-independent manner. These subunits form the heterodimeric actin CP complex that binds the barbed end of actin during filament assembly/disassembly and plays a role in cell morphology, migration, membrane trafficking, and signaling (<xref ref-type="bibr" rid="bib9">Canton et al., 2006</xref>; <xref ref-type="bibr" rid="bib50">Terry et al., 2018</xref>). Mature erythrocytes contain an α<sub>1</sub>β<sub>2</sub> conformation of CP that is present in the cytosol and not associated with the short actin filaments in the erythrocyte membrane skeleton (<xref ref-type="bibr" rid="bib27">Kuhlman and Fowler, 1997</xref>). While pointed end actin CPs like Tropomodulin (Tmod3) coordinate critical steps in late-stage erythropoiesis (<xref ref-type="bibr" rid="bib47">Sui et al., 2014</xref>), the role of barbed end capping molecule CP in erythropoiesis was not previously investigated. We show here that <italic>Capzb</italic> expression opposed erythroid differentiation in fetal liver and stress erythroid precursors, regulated cell size, and promoted cell survival and precursor colony forming activity. The Samd14-CP interaction occurs through a CPI-like domain to mediate Samd14-dependent functions in signaling and progenitor activities. While our studies implicate CP as a mediator of erythropoiesis, the exact mechanism is unclear. Among the potential functions of CP, it is a core component of the dynactin complex which controls early endosome dynamics (<xref ref-type="bibr" rid="bib52">Valetti et al., 1999</xref>). This represents one potential mechanism whereby CP may function in erythroid precursor cell signaling.</p><p>The rate of erythropoiesis can increase by 15–20-fold under stress conditions. Numerous proteins and factors are involved in mechanisms which accelerate, maintain, and ultimately resolve stress erythropoiesis in anemia (<xref ref-type="bibr" rid="bib6">Bresnick et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Paulson et al., 2020</xref>). Stress erythroid progenitors and precursors in spleen and liver have unique cellular behaviors and respond to distinct paracrine signals relative to bone marrow-derived erythroid progenitors (<xref ref-type="bibr" rid="bib19">Harandi et al., 2010</xref>). Illustrating the requirements for Kit signaling in anemia, SCF deletion in spleen endothelial cells attenuates the anemia stress response and reduces the red blood cell counts without affecting bone marrow hematopoiesis (<xref ref-type="bibr" rid="bib24">Inra et al., 2015</xref>). Additional stress-specific signaling molecules BMP-4, hedgehog glucocorticoid and GDF15 promote stress erythroid progenitor expansion and homing (<xref ref-type="bibr" rid="bib5">Bauer et al., 1999</xref>; <xref ref-type="bibr" rid="bib18">Hao et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Lenox et al., 2005</xref>; <xref ref-type="bibr" rid="bib38">Perry et al., 2009</xref>). Transcriptional mechanisms are also intimately involved in erythroid progenitor/precursor stress responses. The transcription factor GATA1 promotes stress erythropoiesis in addition to roles in developmental and physiological erythropoiesis (<xref ref-type="bibr" rid="bib17">Gutiérrez et al., 2008</xref>). GATA1 and related transcription factor GATA2 directly activate Samd14 transcription through an intronic enhancer which is present in a network of other genes predicted to control vital aspects of stress erythropoiesis (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>; <xref ref-type="bibr" rid="bib22">Hewitt et al., 2015</xref>). GATA2 and Samd14, as well as anti-apoptotic genes such as <italic>Bcl2l1</italic>, are transcriptionally elevated in stress erythropoiesis via similar E-box-GATA composite element sequences (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>). As one node of this network, our results in a stress progenitor/precursor genetic rescue system have provided rigorous evidence for a mechanism in which Samd14 upregulation drives stress progenitor activity through its CPI to coordinate stress-dependent signaling mechanisms.</p><p>As a facilitator of cell signaling that is upregulated in response to anemia, Samd14 represents a new constituent driving anemia-specific Kit activities. These conclusions are typified in the <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> mouse, in which the E-box-GATA composite element is selectively required for stress progenitor responses/activities and anemia-dependent Kit signaling. Similar decreases in stress progenitor activities were observed in other genetic models which attenuate Kit activation (e.g. the Kit<sup>Y567F</sup> mouse)(<xref ref-type="bibr" rid="bib2">Agosti et al., 2009</xref>). To establish whether Samd14 mechanisms integrate in other pathways, we also describe a role for Samd14 in Epo signaling. Whereas <italic>Capzb</italic> knockdown lowered Epo signaling, there were no differences in the ability of full length Samd14 and Samd14-∆CPB to activate Epo signaling. Thus, both Samd14 and CP appear to have complex-independent functions in erythroid precursor activity and cell signaling. Together, our findings suggest new models for regulation of cell signal transduction in stress erythropoiesis. We envision two important functions, not necessarily exclusive, that result from the interaction of Samd14 with CP through its CPB domain. First, CP may target Samd14, and therefore, specific signaling activities, at specific locations in the cell important for function, such as membrane-associated receptor complexes. Second, the Samd14-CP interaction may influence activities of the larger CP-containing dynactin complex in endocytic trafficking, impacting the rate of ligand-activated receptor turnover in erythroid cell membranes. It is attractive to propose that the temporary upregulation of Samd14 in acute anemia may be tied to a burst of erythropoiesis by controlling the rate of receptor turnover. The model system used in these studies examines stress-activated erythroid precursors after they have expanded. While this permitted the ex vivo analysis of stress BFU-E in culture systems, fewer BFU-E and CFU-E suggests that Samd14-CP mechanisms may play a role in earlier immature progenitor cells to oppose erythroid maturation. Importantly, while we used PHZ injection to induce acute anemia, <italic>Samd14</italic> expression is also elevated in clinically relevant anemia models induced by severe bleeding and erythroid radioprotection, suggesting that Samd14 mechanisms are not specific to this model. These experiments have taken important steps toward elucidating Samd14 function in acute anemia, the mechanism whereby the Samd14-CP interaction controls erythroid precursor cell signaling, and how cell signaling networks are optimally coordinated in stress erythropoiesis to accelerate and resolve acute anemia.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Samd14</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">Gene ID: NM_146025.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Wild type (C57BL/6 J)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Strain #:000664</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Samd14-Enh<sup>-/-</sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28787589">28787589</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus msculus</italic>)</td><td align="left" valign="bottom">G1E</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9032291/">9032291</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Gift from M. Weiss</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Samd14 (rabbit polyclonal)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28787589/">28787589</ext-link></td><td align="left" valign="bottom">Bresnick lab</td><td align="left" valign="bottom">WB (1:2000)<break/>IP (5 µg)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-HA (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat.: #3724;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1549585">AB_1549585</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-capzα1 (rabbit polyclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">Cat.: #PA5-31026<break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2548500">AB_2548500</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-capzα2 (rabbit polyclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">Cat.: PA5-29982;<break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2547456">AB_2547456</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-capzβ (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat.: #sc-136502;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10610091">AB_10610091</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-capzβ (rabbit polyclonal)</td><td align="left" valign="bottom">Bethyl Lab</td><td align="left" valign="bottom">Cat.: #A304-734A-M</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse anti-Rabbit IgG (Light-Chain Specific)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat.: #93702;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2800208">AB_2800208</ext-link></td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phospho (S473)-AKT (p-AKT) (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat.: #4060;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2315049">AB_2315049</ext-link></td><td align="left" valign="bottom">FC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phospho (Thr202/Tyr204) p44/42 ERK1/2 (p-ERK) (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat.: #9101;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331646">AB_331646</ext-link></td><td align="left" valign="bottom">FC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC-goat anti rabbit IgG</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat.: #111-136-144;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2337987">AB_2337987</ext-link></td><td align="left" valign="bottom">FC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE/Cyanine7(PECy7) anti mouse CD117 (c-Kit) (rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat.: #105,814</td><td align="left" valign="bottom">FC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-mouse Ter119 (rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat.: #116,211</td><td align="left" valign="bottom">FC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE-anti mouse CD71 (rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat.: #113,807</td><td align="left" valign="bottom">FC (1:200)</td></tr><tr><td align="left" valign="bottom">Commercial assay/kit</td><td align="left" valign="bottom">MojoSort Streptavidin Nanobeads</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat.: #480,016</td><td align="left" valign="bottom">FC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-mouse Ki-67 (rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat.: #652,406</td><td align="left" valign="bottom">FC (1:200)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Pacific Blue Annexin V</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat: #640,917</td><td align="left" valign="bottom">FC (1:50)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-rabbit IgG isotype</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat: #10,500 C</td><td align="left" valign="bottom">IP (5 µg)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pMSCV PIG<break/>(plasmid)</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Plasmid #21654;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_21654">Addgene_21654</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Recombinant mouse SCF protein</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">Cat.: #455-MC-050</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Phenylhydrazine</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">P26252</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Flowjo 10.6.2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/solutions/flowjo">https://www.flowjo.com/solutions/flowjo</ext-link>.</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008520">SCR_008520</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/software/fiji/">https://imagej.net/software/fiji/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table><table-wrap-foot><fn><p>SCF: stem cell factor; Samd14-Enh<sup>-/-</sup>: sterile alpha motif domain 14-enhancer.</p></fn></table-wrap-foot></table-wrap><sec id="s4-1"><title>Plasmids and Samd14 constructs</title><p>HA-tagged full-length Samd14, Samd14 lacking the SAM domain (Samd14 ΔSAM) (<xref ref-type="bibr" rid="bib41">Ray et al., 2020</xref>), Samd14 lacking the CPB domain (Samd14 ΔCPB), Samd14 lacking both SAM and CPB domains (Samd14 ΔCPBΔSAM) were cloned into mammalian expression plasmid pMSCV-Puro-IRES-GFP (PIG) (Addgene #21654) using BglII and EcoRI restriction digest sites. Other Samd14 truncation mutants (Samd14-∆38–54, Samd14-∆114–124, Samd14-∆170–180, Samd14-∆272–295) were similarly cloned into pMSCV PIG. HA-tagged chimeric protein in which coding sequences corresponding to 17 amino acid CPI domain of CKIP-1 (from amino acid residues 150–166) replaced the 17 amino acid Samd14 CPB domain at the exact location, termed S14-Ckip CPI, was synthesized (Twist Bioscience) and cloned into pMSCV PIG using BglII and EcoRI restriction digest sites. All plasmids were retrovirally packaged with pCL-Eco (Addgene #12371) in 293T cells. For <italic>Capzb</italic> knockdown, two shRNA targeting exon 5 and exon 6 were synthesized along with a control shRNA targeting the luciferase gene as a 97-nt ultramer (Sigma) containing 22-mer reverted repeats, a 19-nt spacer and restriction sites BglII/XhoI and cloned into pMSCV PIG. shCapzb1: Exon 5 22_mer: <named-content content-type="sequence">TGGAGTGATCCTCATAAAGAAA</named-content>. shCapzb2: Exon 6 22_mer: <named-content content-type="sequence">CGGTGATGCTATGGCTGCAAAC</named-content>.</p></sec><sec id="s4-2"><title>Mice and primary cell isolation</title><p>Samd14-Enh mutant (<italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic>) mice were generated by site-directed TALEN deletion (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>). All animal experiments were carried out with ethical approval of the Institutional Animal Care and Use Committee at the University of Nebraska Medical Center. Fetal liver was isolated at E14.5 from WT mice. Hemolytic anemia was induced by a single dose of freshly prepared PHZ (100 mg/kg) (Sigma) administered subcutaneously in sterile PBS. Spleens were harvested from 8- to 12-week-old mice 3 days post-PHZ injection. Spleens from WT or <italic>Samd14<sup>ΔEnh/ΔEnh</sup></italic> (8–13 weeks old) mice were dissociated, resuspended in PBS with 2% fetal bovine serum (FBS) and passed through a 35 μm nylon filter to obtain single-cell suspensions. Erythroid precursors were isolated using negative selection by lineage-depletion with biotin-conjugated antibodies and MojoSort streptavidin-conjugated magnetic nanobeads (Biolegend): anti-mouse CD3e (clone 145–2 C11), anti-mouse CD11b (clone M1/70), anti-mouse CD19 (clone 6D5), anti-mouse CD45R (B220) (clone RA3-6B2), anti-mouse Gr-1 (clone RB6-C5), anti-mouse Ter119. Following depletion, erythroid precursors were cultured in StemPro-34 media (Invitrogen) containing 2 mM L-glutamine, Pen-Strep, 0.1 mM monothioglycerol, 1 µM dexamethasone, 0.5 U/ml erythropoietin, and 1% mSCF Chinese Hamster Ovary cell conditioned medium. For retroviral infections, 1 × 10<sup>6</sup> lineage<sup>-</sup> cells were added to 100 μl viral supernatant, polybrene (8 μg/ml) and HEPES buffer (10 μl/ml), and spinoculated at 2600 rpm for 90 min at 30°C. Cells were maintained at a density between 0.5 and 1×10<sup>6</sup> cells/ml for 2–3 days.</p></sec><sec id="s4-3"><title>G1E cell culture</title><p><italic>Gata1</italic>-null, mouse embryonic stem cell-derived G1E cells (gift from the Mitch Weiss lab) resemble normal proerythroblasts (<xref ref-type="bibr" rid="bib55">Weiss et al., 1997</xref>). Cells were maintained in IMDM supplemented with 15% fetal bovine serum, 0.5% SCF-conditioned media from CHO cells, 0.1 mM monothioglycerol (Sigma) and 2 U/ml erythropoietin (Amgen). TALEN-mediated deletion of Samd14-Enh was conducted as previously described (<xref ref-type="bibr" rid="bib22">Hewitt et al., 2015</xref>). Retroviral infections were performed by spinoculation (1200 × g for 90 min at 30°C) of 1 × 10<sup>6</sup> G1E cells with 100 μl viral supernatant, polybrene (8 μg/ml) and HEPES buffer (10 μg/ml). FACS-purification of GFP<sup>+</sup> cells was performed 48 hr after infection on a FACSAriaII.</p></sec><sec id="s4-4"><title>CD34<sup>+</sup> cell differentiation</title><p>Peripheral blood CD34<sup>+</sup> cells (Fred Hutchinson) were cultured using a four-phase differentiation protocol as described by <xref ref-type="bibr" rid="bib29">Lee et al., 2015</xref>. Briefly, an initial expansion phase (day 0–4) was followed by three successive differentiation phases, differentiation I (day 5–9), differentiation II (day 10–13), and differentitation III (day 13–21). The basal media contained IMDM, 15% FBS, 2 mM glutamine, holo transferrin (500 µg/ml), and recombinant human insulin (10 µg/ml). The media was supplemented with: 1 μM β-estradiol, 5 ng/ml rhIL-3, 100 ng/ml rhSCF, and 6 U/ml rhEpo for differentiation I; with 50 ng/ml rhSCF and 6 U/ml rhEpo for differentiation II; and with 2 U/ml rhEpo for differentitation III. Cell numbers were maintained at 0.5–1×10<sup>6</sup> cells/ml.</p></sec><sec id="s4-5"><title>Immunoprecipitation</title><p>For endogenous Samd14 immunoprecipitation, 1–2 × 10<sup>7</sup> cells were lysed for 1 hr in 1% NP-40 Lysis buffer (150 nM NaCl, 50 mM Tris pH 8.0, 2 mM DTT, 0.2 mM PMSF, 20 µg/ml leupeptin) on ice. Cell lysates were incubated with 5 µg of either anti-Samd14 antibody (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>) or anti-rabbit IgG isotype (Invitrogen, #10500 C) control overnight. Protein A beads (ThermoFisher #15918–014) were blocked for 1 hr in 1%BSA/PBS prior to IP. Cell lysates were incubated with 60 µl of the preblocked Protein A beads for 2 hr at 4°C. Beads were washed with 1% NP-40 Lysis buffer, boiled in SDS lysis buffer and analyzed by SDS-PAGE.</p><p>For HA pulldown experiments in G1E, 5 × 10<sup>7</sup> GFP<sup>+</sup> G1E-∆Enh cells expressing different Samd14 mutants were collected between days 12 and 14 after sorting for GFP using FACS. Cells were lysed 1 hr in 1% NP-40 Lysis buffer (150 nM NaCl, 50 mM Tris pH 8.0, 2 mM DTT, 0.2 mM PMSF, 20 µg/ml leupeptin) on ice. Protein lysates were incubated with 40 µl slurry of HA-agarose beads (Pierce) overnight. Washed beads were boiled in SDS lysis buffer and analyzed by SDS-PAGE or mass spectrometry.</p></sec><sec id="s4-6"><title>Mass spectrometry</title><p>In-gel samples were reduced with 10 mM DTT and then alkylated with 10 mM iodoacetamide, washed and then digested overnight using trypsin. Tryptic digests were run by LC-MS/MS using a 2 hr gradient on a 0.075 mm × 250 mm Waters CSH C18 column on a U3000 nanoRSLC (Dionex) coupled to a Q-Exactive HF (ThermoScientific) mass spectrometer. Peptides were identified using Mascot (Matrix Science; v.2.6.1), searched with a fragment ion mass tolerance of 0.060 Da and a parent ion tolerance of 10.0 PPM. Deamidated asparagine and glutamine, oxidation of methionine and carbamidomethyl of cysteine, phospho serine, threonine and tyrosine were specified in Mascot as variable modifications. Results were then validated and summarized into Scaffold (Proteome Software; v. 4.8.9) using a 99.0% protein probability with a minimum of two unique peptides with at least 80% peptide probability. Statistically enriched proteins were determined using a 2-way ANOVA.</p></sec><sec id="s4-7"><title>Live cell flow cytometry</title><p>Retrovirally-infected cells were stained with antibodies specific for surface proteins like PE–CD71 (R17217), APC- Ter119 (116212), PE-Cy7- Kit (clone 2B8) (105814), Pacific Blue Annexin V (640917) antibodies for 30 min at 4°C (all from Biolegend). Cells were resuspended with either DAPI or Draq7 (Biolegend) viability dyes as required and analyzed with BD LSR Fortessa. FACS for GFP<sup>+</sup> cells or CD71- and Ter119-fractionation was conducted on a FACSAria II (BD Life Sciences). Data was analyzed with FlowJo v10.6.2.</p></sec><sec id="s4-8"><title>Western blotting</title><p>Proteins were boiled in SDS buffer (25 mM Tris, pH 6.8, 2% β-mercaptoethanol, 3% SDS, 5% bromophenol blue, 5% glycerol) for 10 min, resolved by SDS-PAGE, and detected with Pierce ECL Western blotting substrate (Thermo Scientific) on a LICOR imager. Primary antibodies: polyclonal anti-Samd14 (<xref ref-type="bibr" rid="bib23">Hewitt et al., 2017</xref>), anti-HA (Cell Signaling Technology), anti-β-actin (Cell Signaling Technology), anti-capzα1 (Proteintech and ThermoFisher PA5-31026), anti-capzα2 (ThermoFisher, PA5-29982) anti-capzβ (Santa Cruz; Bethyl Laboratories, A304), anti-Hsc70 (Santa Cruz). Secondary antibodies goat-anti-mouse-IgG-HRP, goat-anti-rabbit-IgG-HRP (Jackson Labs), mouse anti-rabbit IgG (Light-Chain Specific) (#93702; Cell Signaling Technology).</p></sec><sec id="s4-9"><title>Quantitative PCR</title><p>Total RNA was purified from 0.5 to 2 × 10<sup>6</sup> cells in 1 ml TRIzol (ThermoFisher). For cDNA synthesis 1 µg of RNA was incubated with 200 ng oligo(dT) and 50 ng random hexamer primers at 68°C for 10 min. RNA was incubated with M-MLV reverse transcriptase (NEB) with 10 mM dithiothreitol (DTT), RNAsin (Promega), and 0.5 mM deoxynucleoside triphosphates at 42°C for 1 hr, and then heat inactivated at 98°C for 5 min. Real time PCR was performed with 2 µl cDNA, Power SYBR Green (ThermoFisher) and 200 nM of the appropriate primers on the Quant Studio 3 real time PCR system (Applied Biosystems). Relative expression level for each gene was quantified based on a standard curve of serially diluted control cDNA. Negative control reactions were performed on samples in the absence of reverse transcriptase.</p></sec><sec id="s4-10"><title>Colony formation assays</title><p>Spleen cells were isolated from mice 3 days after subcutaneous 100 mg/kg PHZ injection. Lineage-depleted, retrovirally-infected spleen progenitors were cultured for 16–20 hr prior to FACS-purification of GFP + cells. 2×10<sup>4</sup> GFP<sup>+</sup> cells/ml were mixed with Methocult M3434 (STEMCELL Technologies) containing Epo, SCF, IL-3 and IL-6 and plated in replicate 35 mm dishes (2 × 10<sup>4</sup> cells in 1.0 ml) or 6-well plates (1 × 10<sup>4</sup> cells in 0.5 ml). BFU-E colonies were counted 5 days after culturing. CFU-E colonies were counted 2 days after plating.</p></sec><sec id="s4-11"><title>Phospho-flow cytometry</title><p>After 2-day culture, primary spleen cells were serum-starved for 2 hr in 1% BSA/IMDM at 37°C and treated with 10 ng/ml SCF or vehicle for the indicated time. For Epo stimulation (5 U/ml), cells were positively selected by Biotin-Ter119 and MojoSort streptavidin-conjugated magnetic beads. Cells were immediately fixed in 2% paraformaldehyde for 10 min at 37°C and permeabilized in 95% methanol overnight at –20°C. Cells were stained with rabbit antibodies against phospho (S473)-AKT (p-AKT) and phospho (Thr202/Tyr204) p44/42 ERK1/2 (p-ERK) (4060, 9101; Cell Signaling) for 30 min, then incubated in APC-conjugated goat anti-rabbit (1:200), PE-Cy7-conjugated Kit (1:200) and PE-conjugated CD71 (1:200) for 30 min at room temperature. Samples were analyzed using a BD LSR II flow cytometer and gates were selected based on fluorescence minus one control. Values for pAKT and pERK levels were calculated by MFI using FlowJo v10.6.2 (BD Life Sciences) and normalized to the maximum overall value within each experiment (Relative MFI) or as fold change of activation over vehicle treated controls.</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>Statistical analysis was carried out by GraphPad Prism v8 as indicated in the figure legends and represented by *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Methodology</p></fn><fn fn-type="con" id="con4"><p>Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Formal analysis, Investigation, Methodology, Resources, Supervision, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#18-099-08 FC) of the University of Nebraska Medical Center.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-76497-transrepform1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Samd14-interacting proteins.</title><p>Mass spectrometry analysis of IP protein in EV and Samd14 conditions (N=3). Spectral count of each protein, as determined by Scaffold. Statistical significance between EV and HA-Samd14 conditions determined by Scaffold.</p></caption><media xlink:href="elife-76497-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The mass spectrometry proteomics data was deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al, 2019) partner repository with the dataset identifier PXD030467 and 10.6019/PXD030467. All other data generated or analysed during this study are included in the manuscript and supporting file.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><collab>Perez-Riverol et al</collab></person-group><year iso-8601-date="2019">2019</year><data-title>The mass spectrometry proteomics data was deposited to the ProteomeXchange Consortium</data-title><source>PRIDE</source><pub-id pub-id-type="doi">10.6019/PXD030467</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Lara-Astiaso</surname><given-names>D</given-names></name><name><surname>Weiner</surname><given-names>A</given-names></name><name><surname>Lorenzo-Vivas</surname><given-names>E</given-names></name><name><surname>Zaretsky</surname><given-names>I</given-names></name><name><surname>Jaitin</surname><given-names>DA</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Winter</surname><given-names>D</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Friedman</surname><given-names>N</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Chromatin state dynamics during blood formation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60103">GSE60103</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This study was supported by grants to KJH (NIH/National Heart, Lung, and Blood Institute R01 HL155439-01, National Institute of Diabetes and Digestive and Kidney Diseases K01DK113117-03), funding as a project leader in the Nebraska Center for Molecular Target Discovery and Development (DHHS/NIH/NIGMS, 1P20GM121316-01-A1), and funding from the State of Nebraska-Nebraska Stem Cell Research (LB606). The Proteomics &amp; Metabolomics Facility (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_021314">SCR_021314</ext-link>), Nebraska Center for Biotechnology at the University of Nebraska-Lincoln is supported by the Nebraska Research Initiative. We also thank the UNMC Flow Cytometry Research Facility, supported by the Nebraska Research Initiative (NRI) and The Fred and Pamela Buffett Cancer Center’s National Cancer Institute Cancer Support Grant. We thank Dr. Keith R Johnson for thoughtful critiques on this manuscript.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agosti</surname><given-names>V</given-names></name><name><surname>Corbacioglu</surname><given-names>S</given-names></name><name><surname>Ehlers</surname><given-names>I</given-names></name><name><surname>Waskow</surname><given-names>C</given-names></name><name><surname>Sommer</surname><given-names>G</given-names></name><name><surname>Berrozpe</surname><given-names>G</given-names></name><name><surname>Kissel</surname><given-names>H</given-names></name><name><surname>Tucker</surname><given-names>CM</given-names></name><name><surname>Manova</surname><given-names>K</given-names></name><name><surname>Moore</surname><given-names>MAS</given-names></name><name><surname>Rodewald</surname><given-names>HR</given-names></name><name><surname>Besmer</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development</article-title><source>The Journal of Experimental Medicine</source><volume>199</volume><fpage>867</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1084/jem.20031983</pub-id><pub-id pub-id-type="pmid">15024050</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agosti</surname><given-names>V</given-names></name><name><surname>Karur</surname><given-names>V</given-names></name><name><surname>Sathyanarayana</surname><given-names>P</given-names></name><name><surname>Besmer</surname><given-names>P</given-names></name><name><surname>Wojchowski</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis</article-title><source>Experimental Hematology</source><volume>37</volume><fpage>159</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2008.10.009</pub-id><pub-id pub-id-type="pmid">19100679</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aragona</surname><given-names>M</given-names></name><name><surname>Panciera</surname><given-names>T</given-names></name><name><surname>Manfrin</surname><given-names>A</given-names></name><name><surname>Giulitti</surname><given-names>S</given-names></name><name><surname>Michielin</surname><given-names>F</given-names></name><name><surname>Elvassore</surname><given-names>N</given-names></name><name><surname>Dupont</surname><given-names>S</given-names></name><name><surname>Piccolo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors</article-title><source>Cell</source><volume>154</volume><fpage>1047</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.07.042</pub-id><pub-id pub-id-type="pmid">23954413</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astle</surname><given-names>WJ</given-names></name><name><surname>Elding</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Allen</surname><given-names>D</given-names></name><name><surname>Ruklisa</surname><given-names>D</given-names></name><name><surname>Mann</surname><given-names>AL</given-names></name><name><surname>Mead</surname><given-names>D</given-names></name><name><surname>Bouman</surname><given-names>H</given-names></name><name><surname>Riveros-Mckay</surname><given-names>F</given-names></name><name><surname>Kostadima</surname><given-names>MA</given-names></name><name><surname>Lambourne</surname><given-names>JJ</given-names></name><name><surname>Sivapalaratnam</surname><given-names>S</given-names></name><name><surname>Downes</surname><given-names>K</given-names></name><name><surname>Kundu</surname><given-names>K</given-names></name><name><surname>Bomba</surname><given-names>L</given-names></name><name><surname>Berentsen</surname><given-names>K</given-names></name><name><surname>Bradley</surname><given-names>JR</given-names></name><name><surname>Daugherty</surname><given-names>LC</given-names></name><name><surname>Delaneau</surname><given-names>O</given-names></name><name><surname>Freson</surname><given-names>K</given-names></name><name><surname>Garner</surname><given-names>SF</given-names></name><name><surname>Grassi</surname><given-names>L</given-names></name><name><surname>Guerrero</surname><given-names>J</given-names></name><name><surname>Haimel</surname><given-names>M</given-names></name><name><surname>Janssen-Megens</surname><given-names>EM</given-names></name><name><surname>Kaan</surname><given-names>A</given-names></name><name><surname>Kamat</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Mandoli</surname><given-names>A</given-names></name><name><surname>Marchini</surname><given-names>J</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Meacham</surname><given-names>S</given-names></name><name><surname>Megy</surname><given-names>K</given-names></name><name><surname>O’Connell</surname><given-names>J</given-names></name><name><surname>Petersen</surname><given-names>R</given-names></name><name><surname>Sharifi</surname><given-names>N</given-names></name><name><surname>Sheard</surname><given-names>SM</given-names></name><name><surname>Staley</surname><given-names>JR</given-names></name><name><surname>Tuna</surname><given-names>S</given-names></name><name><surname>van der Ent</surname><given-names>M</given-names></name><name><surname>Walter</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>S-Y</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Wilder</surname><given-names>SP</given-names></name><name><surname>Iotchkova</surname><given-names>V</given-names></name><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Di Angelantonio</surname><given-names>E</given-names></name><name><surname>Kaptoge</surname><given-names>S</given-names></name><name><surname>Kuijpers</surname><given-names>TW</given-names></name><name><surname>Carrillo-de-Santa-Pau</surname><given-names>E</given-names></name><name><surname>Juan</surname><given-names>D</given-names></name><name><surname>Rico</surname><given-names>D</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>B</given-names></name><name><surname>Vasquez</surname><given-names>L</given-names></name><name><surname>Kwan</surname><given-names>T</given-names></name><name><surname>Garrido-Martín</surname><given-names>D</given-names></name><name><surname>Watt</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Guigo</surname><given-names>R</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Paul</surname><given-names>DS</given-names></name><name><surname>Pastinen</surname><given-names>T</given-names></name><name><surname>Bujold</surname><given-names>D</given-names></name><name><surname>Bourque</surname><given-names>G</given-names></name><name><surname>Frontini</surname><given-names>M</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease</article-title><source>Cell</source><volume>167</volume><fpage>1415</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.042</pub-id><pub-id pub-id-type="pmid">27863252</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>A</given-names></name><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Wessely</surname><given-names>O</given-names></name><name><surname>Kellendonk</surname><given-names>C</given-names></name><name><surname>Reichardt</surname><given-names>HM</given-names></name><name><surname>Steinlein</surname><given-names>P</given-names></name><name><surname>Schütz</surname><given-names>G</given-names></name><name><surname>Beug</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The glucocorticoid receptor is required for stress erythropoiesis</article-title><source>Genes &amp; Development</source><volume>13</volume><fpage>2996</fpage><lpage>3002</lpage><pub-id pub-id-type="doi">10.1101/gad.13.22.2996</pub-id><pub-id pub-id-type="pmid">10580006</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bresnick</surname><given-names>EH</given-names></name><name><surname>Hewitt</surname><given-names>KJ</given-names></name><name><surname>Mehta</surname><given-names>C</given-names></name><name><surname>Keles</surname><given-names>S</given-names></name><name><surname>Paulson</surname><given-names>RF</given-names></name><name><surname>Johnson</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond</article-title><source>Development</source><volume>145</volume><elocation-id>dev151423</elocation-id><pub-id pub-id-type="doi">10.1242/dev.151423</pub-id><pub-id pub-id-type="pmid">29321181</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broudy</surname><given-names>VC</given-names></name><name><surname>Lin</surname><given-names>NL</given-names></name><name><surname>Priestley</surname><given-names>GV</given-names></name><name><surname>Nocka</surname><given-names>K</given-names></name><name><surname>Wolf</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen</article-title><source>Blood</source><volume>88</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1182/blood.V88.1.75.75</pub-id><pub-id pub-id-type="pmid">8704204</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruck</surname><given-names>S</given-names></name><name><surname>Huber</surname><given-names>TB</given-names></name><name><surname>Ingham</surname><given-names>RJ</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Niederstrasser</surname><given-names>H</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name><name><surname>Pawson</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Shaw</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Identification of a novel inhibitory actin-capping protein binding motif in CD2-associated protein</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>19196</fpage><lpage>19203</lpage><pub-id pub-id-type="doi">10.1074/jbc.M600166200</pub-id><pub-id pub-id-type="pmid">16707503</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canton</surname><given-names>DA</given-names></name><name><surname>Olsten</surname><given-names>MEK</given-names></name><name><surname>Niederstrasser</surname><given-names>H</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Litchfield</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The role of CKIP-1 in cell morphology depends on its interaction with actin-capping protein</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>36347</fpage><lpage>36359</lpage><pub-id pub-id-type="doi">10.1074/jbc.M607595200</pub-id><pub-id pub-id-type="pmid">16987810</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casella</surname><given-names>JF</given-names></name><name><surname>Craig</surname><given-names>SW</given-names></name><name><surname>Maack</surname><given-names>DJ</given-names></name><name><surname>Brown</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Cap Z(36/32), a barbed end actin-capping protein, is a component of the Z-line of skeletal muscle</article-title><source>The Journal of Cell Biology</source><volume>105</volume><fpage>371</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1083/jcb.105.1.371</pub-id><pub-id pub-id-type="pmid">3301868</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>M</given-names></name><name><surname>McConnell</surname><given-names>P</given-names></name><name><surname>Schafer</surname><given-names>DA</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CPI motif interaction is necessary for capping protein function in cells</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8415</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9415</pub-id><pub-id pub-id-type="pmid">26412145</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehrmann</surname><given-names>RSN</given-names></name><name><surname>Jansen</surname><given-names>RC</given-names></name><name><surname>Veldink</surname><given-names>JH</given-names></name><name><surname>Westra</surname><given-names>HJ</given-names></name><name><surname>Arends</surname><given-names>D</given-names></name><name><surname>Bonder</surname><given-names>MJ</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Deelen</surname><given-names>P</given-names></name><name><surname>Groen</surname><given-names>HJM</given-names></name><name><surname>Smolonska</surname><given-names>A</given-names></name><name><surname>Weersma</surname><given-names>RK</given-names></name><name><surname>Hofstra</surname><given-names>RMW</given-names></name><name><surname>Buurman</surname><given-names>WA</given-names></name><name><surname>Rensen</surname><given-names>S</given-names></name><name><surname>Wolfs</surname><given-names>MGM</given-names></name><name><surname>Platteel</surname><given-names>M</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Elbers</surname><given-names>CC</given-names></name><name><surname>Festen</surname><given-names>EM</given-names></name><name><surname>Trynka</surname><given-names>G</given-names></name><name><surname>Hofker</surname><given-names>MH</given-names></name><name><surname>Saris</surname><given-names>CGJ</given-names></name><name><surname>Ophoff</surname><given-names>RA</given-names></name><name><surname>van den Berg</surname><given-names>LH</given-names></name><name><surname>van Heel</surname><given-names>DA</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Te Meerman</surname><given-names>GJ</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA</article-title><source>PLOS Genetics</source><volume>7</volume><elocation-id>e1002197</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002197</pub-id><pub-id pub-id-type="pmid">21829388</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flygare</surname><given-names>J</given-names></name><name><surname>Rayon Estrada</surname><given-names>V</given-names></name><name><surname>Shin</surname><given-names>C</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Lodish</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>HIF1alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal</article-title><source>Blood</source><volume>117</volume><fpage>3435</fpage><lpage>3444</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-07-295550</pub-id><pub-id pub-id-type="pmid">21177435</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>K</given-names></name><name><surname>Bennett</surname><given-names>V</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Modulation of spectrin-actin assembly by erythrocyte adducin</article-title><source>Nature</source><volume>328</volume><fpage>359</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1038/328359a0</pub-id><pub-id pub-id-type="pmid">3600811</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname><given-names>EF</given-names></name><name><surname>Ducamp</surname><given-names>S</given-names></name><name><surname>Leduc</surname><given-names>M</given-names></name><name><surname>Salnot</surname><given-names>V</given-names></name><name><surname>Guillonneau</surname><given-names>F</given-names></name><name><surname>Dussiot</surname><given-names>M</given-names></name><name><surname>Hale</surname><given-names>J</given-names></name><name><surname>Giarratana</surname><given-names>MC</given-names></name><name><surname>Raimbault</surname><given-names>A</given-names></name><name><surname>Douay</surname><given-names>L</given-names></name><name><surname>Lacombe</surname><given-names>C</given-names></name><name><surname>Mohandas</surname><given-names>N</given-names></name><name><surname>Verdier</surname><given-names>F</given-names></name><name><surname>Zermati</surname><given-names>Y</given-names></name><name><surname>Mayeux</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Comprehensive Proteomic Analysis of Human Erythropoiesis</article-title><source>Cell Reports</source><volume>16</volume><fpage>1470</fpage><lpage>1484</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.06.085</pub-id><pub-id pub-id-type="pmid">27452463</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geissler</surname><given-names>EN</given-names></name><name><surname>Russell</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. I. Influence upon hematopoietic stem cells</article-title><source>Experimental Hematology</source><volume>11</volume><fpage>452</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">6352297</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutiérrez</surname><given-names>L</given-names></name><name><surname>Tsukamoto</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Yamamoto-Mukai</surname><given-names>H</given-names></name><name><surname>Philipsen</surname><given-names>S</given-names></name><name><surname>Ohneda</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis</article-title><source>Blood</source><volume>111</volume><fpage>4375</fpage><lpage>4385</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-09-115121</pub-id><pub-id pub-id-type="pmid">18258797</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Xiang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>DC</given-names></name><name><surname>Fraser</surname><given-names>JW</given-names></name><name><surname>Ruan</surname><given-names>B</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Patterson</surname><given-names>AD</given-names></name><name><surname>Lai</surname><given-names>ZC</given-names></name><name><surname>Paulson</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gdf15 regulates murine stress erythroid progenitor proliferation and the development of the stress erythropoiesis niche</article-title><source>Blood Advances</source><volume>3</volume><fpage>2205</fpage><lpage>2217</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2019000375</pub-id><pub-id pub-id-type="pmid">31324641</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harandi</surname><given-names>OF</given-names></name><name><surname>Hedge</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>DC</given-names></name><name><surname>McKeone</surname><given-names>D</given-names></name><name><surname>Paulson</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Murine erythroid short-term radioprotection requires a BMP4-dependent, self-renewing population of stress erythroid progenitors</article-title><source>The Journal of Clinical Investigation</source><volume>120</volume><fpage>4507</fpage><lpage>4519</lpage><pub-id pub-id-type="doi">10.1172/JCI41291</pub-id><pub-id pub-id-type="pmid">21060151</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>DE</given-names></name><name><surname>Russell</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="1972">1972</year><article-title>The response of W-W v and Sl-Sl d anaemic mice to haemopoietic stimuli</article-title><source>British Journal of Haematology</source><volume>22</volume><fpage>155</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2141.1972.tb08797.x</pub-id><pub-id pub-id-type="pmid">5057942</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Valladares</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Kannan</surname><given-names>B</given-names></name><name><surname>Tung</surname><given-names>A</given-names></name><name><surname>Aguda</surname><given-names>AH</given-names></name><name><surname>Larsson</surname><given-names>M</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Robinson</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Structural characterization of a capping protein interaction motif defines a family of actin filament regulators</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>17</volume><fpage>497</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1792</pub-id><pub-id pub-id-type="pmid">20357771</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>KJ</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Devadas</surname><given-names>P</given-names></name><name><surname>Prathibha</surname><given-names>R</given-names></name><name><surname>Zuo</surname><given-names>C</given-names></name><name><surname>Sanalkumar</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>KD</given-names></name><name><surname>Kang</surname><given-names>YA</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Dewey</surname><given-names>CN</given-names></name><name><surname>Keles</surname><given-names>S</given-names></name><name><surname>Bresnick</surname><given-names>EH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hematopoietic Signaling Mechanism Revealed from a Stem/Progenitor Cell Cistrome</article-title><source>Molecular Cell</source><volume>59</volume><fpage>62</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.05.020</pub-id><pub-id pub-id-type="pmid">26073540</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>KJ</given-names></name><name><surname>Katsumura</surname><given-names>KR</given-names></name><name><surname>Matson</surname><given-names>DR</given-names></name><name><surname>Devadas</surname><given-names>P</given-names></name><name><surname>Tanimura</surname><given-names>N</given-names></name><name><surname>Hebert</surname><given-names>AS</given-names></name><name><surname>Coon</surname><given-names>JJ</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Dewey</surname><given-names>CN</given-names></name><name><surname>Keles</surname><given-names>S</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Paulson</surname><given-names>RF</given-names></name><name><surname>Bresnick</surname><given-names>EH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>GATA Factor-Regulated Samd14 Enhancer Confers Red Blood Cell Regeneration and Survival in Severe Anemia</article-title><source>Developmental Cell</source><volume>42</volume><fpage>213</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.07.009</pub-id><pub-id pub-id-type="pmid">28787589</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inra</surname><given-names>CN</given-names></name><name><surname>Zhou</surname><given-names>BO</given-names></name><name><surname>Acar</surname><given-names>M</given-names></name><name><surname>Murphy</surname><given-names>MM</given-names></name><name><surname>Richardson</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Morrison</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A perisinusoidal niche for extramedullary haematopoiesis in the spleen</article-title><source>Nature</source><volume>527</volume><fpage>466</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1038/nature15530</pub-id><pub-id pub-id-type="pmid">26570997</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isenberg</surname><given-names>G</given-names></name><name><surname>Aebi</surname><given-names>U</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>An actin-binding protein from Acanthamoeba regulates actin filament polymerization and interactions</article-title><source>Nature</source><volume>288</volume><fpage>455</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1038/288455a0</pub-id><pub-id pub-id-type="pmid">6893736</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>AB</given-names></name><name><surname>Hilton</surname><given-names>DM</given-names></name><name><surname>McConnell</surname><given-names>P</given-names></name><name><surname>Johnson</surname><given-names>B</given-names></name><name><surname>Harris</surname><given-names>MT</given-names></name><name><surname>Simone</surname><given-names>A</given-names></name><name><surname>Amarasinghe</surname><given-names>GK</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Goode</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A novel mode of capping protein-regulation by twinfilin</article-title><source>eLife</source><volume>7</volume><elocation-id>e41313</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.41313</pub-id><pub-id pub-id-type="pmid">30351272</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhlman</surname><given-names>PA</given-names></name><name><surname>Fowler</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Purification and characterization of an alpha 1 beta 2 isoform of CapZ from human erythrocytes: cytosolic location and inability to bind to Mg2+ ghosts suggest that erythrocyte actin filaments are capped by adducin</article-title><source>Biochemistry</source><volume>36</volume><fpage>13461</fpage><lpage>13472</lpage><pub-id pub-id-type="doi">10.1021/bi970601b</pub-id><pub-id pub-id-type="pmid">9354614</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara-Astiaso</surname><given-names>D</given-names></name><name><surname>Weiner</surname><given-names>A</given-names></name><name><surname>Lorenzo-Vivas</surname><given-names>E</given-names></name><name><surname>Zaretsky</surname><given-names>I</given-names></name><name><surname>Jaitin</surname><given-names>DA</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Winter</surname><given-names>D</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Friedman</surname><given-names>N</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chromatin state dynamics during blood formation</article-title><source>Science</source><volume>345</volume><fpage>943</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1126/science.1256271</pub-id><pub-id pub-id-type="pmid">25103404</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Barrasa</surname><given-names>MI</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Elmes</surname><given-names>RR</given-names></name><name><surname>Peters</surname><given-names>LL</given-names></name><name><surname>Lodish</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal</article-title><source>Nature</source><volume>522</volume><fpage>474</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1038/nature14326</pub-id><pub-id pub-id-type="pmid">25970251</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennartsson</surname><given-names>J</given-names></name><name><surname>Rönnstrand</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stem cell factor receptor/c-Kit: from basic science to clinical implications</article-title><source>Physiological Reviews</source><volume>92</volume><fpage>1619</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1152/physrev.00046.2011</pub-id><pub-id pub-id-type="pmid">23073628</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenox</surname><given-names>LE</given-names></name><name><surname>Perry</surname><given-names>JM</given-names></name><name><surname>Paulson</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>BMP4 and Madh5 regulate the erythroid response to acute anemia</article-title><source>Blood</source><volume>105</volume><fpage>2741</fpage><lpage>2748</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-02-0703</pub-id><pub-id pub-id-type="pmid">15591122</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenox</surname><given-names>LE</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Hegde</surname><given-names>S</given-names></name><name><surname>Paulson</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Extramedullary erythropoiesis in the adult liver requires BMP-4/Smad5-dependent signaling</article-title><source>Experimental Hematology</source><volume>37</volume><fpage>549</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2009.01.004</pub-id><pub-id pub-id-type="pmid">19375646</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Natarajan</surname><given-names>A</given-names></name><name><surname>Ezike</surname><given-names>J</given-names></name><name><surname>Barrasa</surname><given-names>MI</given-names></name><name><surname>Le</surname><given-names>Y</given-names></name><name><surname>Feder</surname><given-names>ZA</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Markoulaki</surname><given-names>S</given-names></name><name><surname>Lodish</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Rate of Progression through a Continuum of Transit-Amplifying Progenitor Cell States Regulates Blood Cell Production</article-title><source>Developmental Cell</source><volume>49</volume><fpage>118</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.01.026</pub-id><pub-id pub-id-type="pmid">30827895</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Pop</surname><given-names>R</given-names></name><name><surname>Sadegh</surname><given-names>C</given-names></name><name><surname>Brugnara</surname><given-names>C</given-names></name><name><surname>Haase</surname><given-names>VH</given-names></name><name><surname>Socolovsky</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo</article-title><source>Blood</source><volume>108</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-11-4458</pub-id><pub-id pub-id-type="pmid">16527892</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munugalavadla</surname><given-names>V</given-names></name><name><surname>Kapur</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Role of c-Kit and erythropoietin receptor in erythropoiesis</article-title><source>Critical Reviews in Oncology/Hematology</source><volume>54</volume><fpage>63</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2004.11.005</pub-id><pub-id pub-id-type="pmid">15780908</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagamachi</surname><given-names>A</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Asou</surname><given-names>H</given-names></name><name><surname>Ozaki</surname><given-names>Y</given-names></name><name><surname>Aki</surname><given-names>D</given-names></name><name><surname>Kanai</surname><given-names>A</given-names></name><name><surname>Takubo</surname><given-names>K</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Wolff</surname><given-names>L</given-names></name><name><surname>Honda</surname><given-names>H</given-names></name><name><surname>Inaba</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7</article-title><source>Cancer Cell</source><volume>24</volume><fpage>305</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2013.08.011</pub-id><pub-id pub-id-type="pmid">24029230</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulson</surname><given-names>RF</given-names></name><name><surname>Hariharan</surname><given-names>S</given-names></name><name><surname>Little</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Stress erythropoiesis: definitions and models for its study</article-title><source>Experimental Hematology</source><volume>89</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2020.07.011</pub-id><pub-id pub-id-type="pmid">32750404</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>JM</given-names></name><name><surname>Harandi</surname><given-names>OF</given-names></name><name><surname>Porayette</surname><given-names>P</given-names></name><name><surname>Hegde</surname><given-names>S</given-names></name><name><surname>Kannan</surname><given-names>AK</given-names></name><name><surname>Paulson</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Maintenance of the BMP4-dependent stress erythropoiesis pathway in the murine spleen requires hedgehog signaling</article-title><source>Blood</source><volume>113</volume><fpage>911</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-03-147892</pub-id><pub-id pub-id-type="pmid">18927434</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittoni</surname><given-names>P</given-names></name><name><surname>Piconese</surname><given-names>S</given-names></name><name><surname>Tripodo</surname><given-names>C</given-names></name><name><surname>Colombo</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors</article-title><source>Oncogene</source><volume>30</volume><fpage>757</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1038/onc.2010.494</pub-id><pub-id pub-id-type="pmid">21057534</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyle</surname><given-names>WG</given-names></name><name><surname>Hart</surname><given-names>MC</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Sumandea</surname><given-names>MP</given-names></name><name><surname>de Tombe</surname><given-names>PP</given-names></name><name><surname>Solaro</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Actin capping protein: an essential element in protein kinase signaling to the myofilaments</article-title><source>Circulation Research</source><volume>90</volume><fpage>1299</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1161/01.res.0000024389.03152.22</pub-id><pub-id pub-id-type="pmid">12089068</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>S</given-names></name><name><surname>Chee</surname><given-names>L</given-names></name><name><surname>Matson</surname><given-names>DR</given-names></name><name><surname>Palermo</surname><given-names>NY</given-names></name><name><surname>Bresnick</surname><given-names>EH</given-names></name><name><surname>Hewitt</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sterile α-motif domain requirement for cellular signaling and survival</article-title><source>The Journal of Biological Chemistry</source><volume>295</volume><fpage>7113</fpage><lpage>7125</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA119.011895</pub-id><pub-id pub-id-type="pmid">32241909</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>DA</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Control of actin assembly at filament ends</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>11</volume><fpage>497</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1146/annurev.cb.11.110195.002433</pub-id><pub-id pub-id-type="pmid">8689567</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroer</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Dynactin</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>20</volume><fpage>759</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.20.012103.094623</pub-id><pub-id pub-id-type="pmid">15473859</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sizonenko</surname><given-names>GI</given-names></name><name><surname>Karpova</surname><given-names>TS</given-names></name><name><surname>Gattermeir</surname><given-names>DJ</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Mutational analysis of capping protein function in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular Biology of the Cell</source><volume>7</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1091/mbc.7.1.1</pub-id><pub-id pub-id-type="pmid">8741835</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Socolovsky</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular insights into stress erythropoiesis</article-title><source>Current Opinion in Hematology</source><volume>14</volume><fpage>215</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1097/MOH.0b013e3280de2bf1</pub-id><pub-id pub-id-type="pmid">17414210</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solís</surname><given-names>C</given-names></name><name><surname>Russell</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CapZ integrates several signaling pathways in response to mechanical stiffness</article-title><source>The Journal of General Physiology</source><volume>151</volume><fpage>660</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1085/jgp.201812199</pub-id><pub-id pub-id-type="pmid">30808692</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sui</surname><given-names>Z</given-names></name><name><surname>Nowak</surname><given-names>RB</given-names></name><name><surname>Bacconi</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>NE</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wickrema</surname><given-names>A</given-names></name><name><surname>An</surname><given-names>X</given-names></name><name><surname>Fowler</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liver</article-title><source>Blood</source><volume>123</volume><fpage>758</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-03-492710</pub-id><pub-id pub-id-type="pmid">24159174</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Iijima</surname><given-names>T</given-names></name><name><surname>Kano</surname><given-names>J</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Morishita</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>C</given-names></name><name><surname>Anami</surname><given-names>Y</given-names></name><name><surname>Noguchi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Frequent aberrant methylation of the promoter region of sterile alpha motif domain 14 in pulmonary adenocarcinoma</article-title><source>Cancer Science</source><volume>99</volume><fpage>2177</fpage><lpage>2184</lpage><pub-id pub-id-type="doi">10.1111/j.1349-7006.2008.00965.x</pub-id><pub-id pub-id-type="pmid">18823374</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>LKH</given-names></name><name><surname>Pereira</surname><given-names>BA</given-names></name><name><surname>Keerthikumar</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Niranjan</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>SN</given-names></name><name><surname>Richards</surname><given-names>M</given-names></name><name><surname>Schittenhelm</surname><given-names>RB</given-names></name><name><surname>Furic</surname><given-names>L</given-names></name><name><surname>Goode</surname><given-names>DL</given-names></name><name><surname>Lawrence</surname><given-names>MG</given-names></name><name><surname>Taylor</surname><given-names>RA</given-names></name><name><surname>Ellem</surname><given-names>SJ</given-names></name><name><surname>Risbridger</surname><given-names>GP</given-names></name><name><surname>Lister</surname><given-names>NL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment</article-title><source>Cancers</source><volume>13</volume><elocation-id>1237</elocation-id><pub-id pub-id-type="doi">10.3390/cancers13061237</pub-id><pub-id pub-id-type="pmid">33799802</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terry</surname><given-names>SJ</given-names></name><name><surname>Donà</surname><given-names>F</given-names></name><name><surname>Osenberg</surname><given-names>P</given-names></name><name><surname>Carlton</surname><given-names>JG</given-names></name><name><surname>Eggert</surname><given-names>US</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Capping protein regulates actin dynamics during cytokinetic midbody maturation</article-title><source>PNAS</source><volume>115</volume><fpage>2138</fpage><lpage>2143</lpage><pub-id pub-id-type="doi">10.1073/pnas.1722281115</pub-id><pub-id pub-id-type="pmid">29439200</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timokhina</surname><given-names>I</given-names></name><name><surname>Kissel</surname><given-names>H</given-names></name><name><surname>Stella</surname><given-names>G</given-names></name><name><surname>Besmer</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation</article-title><source>The EMBO Journal</source><volume>17</volume><fpage>6250</fpage><lpage>6262</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.21.6250</pub-id><pub-id pub-id-type="pmid">9799234</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valetti</surname><given-names>C</given-names></name><name><surname>Wetzel</surname><given-names>DM</given-names></name><name><surname>Schrader</surname><given-names>M</given-names></name><name><surname>Hasbani</surname><given-names>MJ</given-names></name><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Kreis</surname><given-names>TE</given-names></name><name><surname>Schroer</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Role of dynactin in endocytic traffic: effects of dynamitin overexpression and colocalization with CLIP-170</article-title><source>Molecular Biology of the Cell</source><volume>10</volume><fpage>4107</fpage><lpage>4120</lpage><pub-id pub-id-type="doi">10.1091/mbc.10.12.4107</pub-id><pub-id pub-id-type="pmid">10588646</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vind</surname><given-names>AC</given-names></name><name><surname>Snieckute</surname><given-names>G</given-names></name><name><surname>Blasius</surname><given-names>M</given-names></name><name><surname>Tiedje</surname><given-names>C</given-names></name><name><surname>Krogh</surname><given-names>N</given-names></name><name><surname>Bekker-Jensen</surname><given-names>DB</given-names></name><name><surname>Andersen</surname><given-names>KL</given-names></name><name><surname>Nordgaard</surname><given-names>C</given-names></name><name><surname>Tollenaere</surname><given-names>MAX</given-names></name><name><surname>Lund</surname><given-names>AH</given-names></name><name><surname>Olsen</surname><given-names>JV</given-names></name><name><surname>Nielsen</surname><given-names>H</given-names></name><name><surname>Bekker-Jensen</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ZAKα Recognizes Stalled Ribosomes through Partially Redundant Sensor Domains</article-title><source>Molecular Cell</source><volume>78</volume><fpage>700</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.03.021</pub-id><pub-id pub-id-type="pmid">32289254</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions</article-title><source>eLife</source><volume>7</volume><elocation-id>e35677</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35677</pub-id><pub-id pub-id-type="pmid">29749928</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>MJ</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line</article-title><source>Molecular and Cellular Biology</source><volume>17</volume><fpage>1642</fpage><lpage>1651</lpage><pub-id pub-id-type="doi">10.1128/MCB.17.3.1642</pub-id><pub-id pub-id-type="pmid">9032291</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>DC</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Paulson</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors</article-title><source>Blood</source><volume>125</volume><fpage>1803</fpage><lpage>1812</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-07-591453</pub-id><pub-id pub-id-type="pmid">25608563</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Chang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer</article-title><source>International Journal of Clinical Oncology</source><volume>25</volume><fpage>1105</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1007/s10147-020-01647-4</pub-id><pub-id pub-id-type="pmid">32206938</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Pring</surname><given-names>M</given-names></name><name><surname>Wear</surname><given-names>MA</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Svitkina</surname><given-names>TM</given-names></name><name><surname>Zigmond</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mammalian CARMIL inhibits actin filament capping by capping protein</article-title><source>Developmental Cell</source><volume>9</volume><fpage>209</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.06.008</pub-id><pub-id pub-id-type="pmid">16054028</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Socolovsky</surname><given-names>M</given-names></name><name><surname>Gross</surname><given-names>AW</given-names></name><name><surname>Lodish</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system</article-title><source>Blood</source><volume>102</volume><fpage>3938</fpage><lpage>3946</lpage><pub-id pub-id-type="doi">10.1182/blood-2003-05-1479</pub-id><pub-id pub-id-type="pmid">12907435</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76497.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jian</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.12.31.474625" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.12.31.474625"/></front-stub><body><p>This study describes a new mechanism involving Samd14 and F-actin capping protein (CP) complex formation in the regulation of stress erythropoiesis. Through orthogonal biochemical, cellular, and genetic complementation assays, the authors provide evidence that the Samd14-CP interaction is required for the proper regulation of SCF/Kit signaling in erythroid precursors in response to acute anemia. The Samd14-CP-mediated mechanism may have implications in modulating the receptor tyrosine kinase signaling in physiological and pathological conditions.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76497.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Xu</surname><given-names>Jian</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Xu</surname><given-names>Jian</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05byvp690</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Paulson</surname><given-names>Robert</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.12.31.474625">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.12.31.474625v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Functional Requirements for a Samd14-Capping Protein Complex in Stress Erythropoiesis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Jian Xu as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Utpal Banerjee as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Robert Paulson (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission. Besides the essential revisions listed below, we also provide the comments from individual reviewers for your reference as you prepare the revisions.</p><p>Essential revisions:</p><p>1. Additional data are needed to support the role of Capzb in erythropoiesis. Suggested studies include cytospins, the viability and proliferation of the Capzb KD cells, and/or overexpression studies. It would be of interest to also examine some of the effects caused by Capzb knockdown in Samd14-Enhancer knockout cells.</p><p>2. Obtain additional insights into the mechanisms that contribute to the erythroid stage-specific effects. For example, Samd14 is significantly upregulated during stress erythropoiesis but CP expression is not affected. Is the Samd14-CP interaction via CPB dynamically regulated by stress erythropoiesis and/or by Kit signaling in a differentiation stage-specific manner?</p><p>3. Functional assays (colony forming ability, proliferation, etc) or alternate assessment of Kit/EPO signaling would help further support conclusions.</p><p>4. Apart from pAKT and pERK, it would be helpful to obtain additional mechanistic insights into how the Samd14-CP complex regulates Kit signaling. The authors should consider one or few of the suggested experiments such as the use of Kit expression cell line and the effects on gene expression with knockdown of the capping proteins,</p><p>5. Given the observation that BFU-Es are down, it would be helpful to determine whether the early Kit+Sca1+CD133+ progenitors are affected, for example the expansion of these cells in culture with knockdown of the capping complex.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>This is a well-developed manuscript with a number of interesting findings. The functional and biochemical studies of Samd14-CP interaction in erythropoiesis in response to stress-induced signaling were well executed, and the results were appropriately discussed. This reviewer has a few points to further enhance the strengths of the main conclusions.</p><p>1. The authors provided evidence that Capza/b knockdown largely phenocopies Samd14 deficiency in PHZ-induced erythroid stress. To provide additional evidence for the Samd14-CP complex interaction in stress erythropoiesis, it would be of interest to perform Capza/b knockdown in Samd14-Enhancer knockout cells. These studies may further reveal whether the CP complex regulates erythroid cell maturation in a Samd14-dependent manner.</p><p>2. The model that Samd14-CP interaction regulates c-Kit but not Epo signaling is based mostly on genetic complementation assay with expression of WT or various Samd14 mutants, as well as the downstream effects on signaling cascades (i.e. phosphorylation of AKT and ERK1/2). While informative, it would be interesting to obtain further insights into the mechanisms that may contribute to the stage-specific effects. For example, Samd14 is significantly upregulated during stress erythropoiesis but CP expression is not affected. Is the Samd14-CP interaction via CPB dynamically regulated by stress erythropoiesis and/or by c-Kit signaling in a differentiation stage-specific manner?</p><p>3. Given that the main findings were based on PHZ-mediated anemic stress, it would be helpful for the authors to further discuss their findings in the context of more physiologically relevant models of stress erythropoiesis and pathologic settings.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>A few more granular comments for the authors:</p><p>It is not clear from the apoptosis analyses discussed in 238-246 if there was an overall increase in cell death, or only in early/ late apoptosis. Looking at the specific viability of the R2/R3 cells would help to understand if they are maturing at an increased rate, or if they are dying. Also, it's not clear from the data presented that the role of Capzb is limited to maintaining viability in context of anemic stress. Does KD of Capzb in non-stressed erythroblasts or cell lines (like G1E or CD34)+ lead to loss of viability?</p><p>For the studies in Figure 5A, it is not clear what cell populations are being studied. Only a fairly narrow window of erythroblasts are typically positive for both Cd71 and kit (CFU-E and ProE), so it seems somewhat counterintuitive to parse this population further by CD71 level.</p><p>shRNA can have off target effects in erythroid cells. Use of alternate methods such as TALENs or CRISPR/Cas9 to disrupt Capzb would further support the conclusions that the CP complex has a role in erythropoiesis.</p><p>It is interesting that the CP components are downregulated following anemic stress, while SAMD14 goes up. How do these expression changes fit into the model of SAMD14-CP interaction in stress erythroid progenitors? Did this change occur on the protein level as well?</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The paper from Ray et al., does an excellent job of identifying new components of the Kit/SCF signaling pathway. The authors have built on previous data showing the Samd14 plays a key role in regulating increased activation of Erk and Akt signaling pathways downstream of Kit receptor during stress erythropoiesis. The CP complex was not previously identified as a component of this pathway. The biochemical analysis is a strength. The weaknesses of the paper have more to do with the phenotypic analysis. The paper does not extend the Samd14 findings that Erk and Akt signaling is affected. It would be greatly improved, if there were mechanistic data showing how the Samd14-CP complex interaction affected Kit signaling. The second weakness is in the analysis of stress erythropoiesis. The data from Samd14 and the knockdown of Capz show a defect in BFU-E. However, the analysis focuses on later stage cells and on cells isolated from spleens after the expansion of the stress BFU-E population has occurred. Furthermore, stress BFU-E respond to different conditions (Epo + BMP4 + SCF at 1% O2) than steady state BFU-E (Epo + IL-3 or SCF), the conditions used here were for steady state BFU-E so some aspects of the role of the CP complex in stress erythropoiesis may be lost. The discussion would also be improved if the role of Samd14/CP complex was put into the developmental context of stress erythropoiesis. The fact that you have fewer BFU-E and when you look at erythroblasts in your cultures, they skew towards more mature cells suggests the defect is in the proliferation of immature cells and the ability of these cells to resist differentiation.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76497.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. Additional data are needed to support the role of Capzb in erythropoiesis. Suggested studies include cytospins, the viability and proliferation of the Capzb KD cells, and/or overexpression studies. It would be of interest to also examine some of the effects caused by Capzb knockdown in Samd14-Enhancer knockout cells.</p></disp-quote><p>Since the role of Capzb in erythropoiesis had not been studied, we conducted additional experiments to confirm that Capzb knockdown alters erythroid maturation in erythroid precursors. The revised manuscript extends our analysis in the following ways:</p><p>1) Cytospins and Wright-Giemsa staining were conducted on control and shCapzb knockdown cells to compare cellular morphology (Figure 3F). Capzb knockdown cultures contained more cells consistent with the morphology and staining of mature erythroblasts and reticulocytes than controls, supporting flow cytometry data that Capzb knockdown cells are smaller and more differentiated than control cells.</p><p>2) We quantified cell viability in control vs shCapzb cells. At all immunophenotypically-defined stages of erythroid differentiation, we observed an increased accumulation of dead (DAPI+) cells in shCapzb knockdown vs control. These findings correlated with increased late apoptosis in Figure 3.</p><p>3) We assessed proliferation using a Ki67 stain in shCapzb vs control cells. In CD71low/med cells, proliferation was higher in Capzb knockdown cells. These results are consistent with prior reports in adherent cell cultures, in which knockdown increased proliferation (Aragona et al., Cell 2013).</p><p>4) We tested whether Capzb knockdown elicited similar or distinct responses in Samd14-Enh<sup>-/-</sup> cells as wildtype cells. Like WT cells, Capzb knockdown in Enh<sup>-/-</sup> spleen erythroid precursors decreased R2/3 cell percentages and increased R4/R5 cell percentages compared to controls. Capzb knockdown in Enh<sup>-/-</sup> cells decreased CFU-E potential vs. WT controls. These results suggested that the role of Capzb in erythropoiesis extends beyond just the Samd14-CP complex interaction. Experiments are quantitated in Supplemental Figure 2 and discussed in the manuscript on page x, line x. Given the wide-ranging role of CP in cell biology, and CP complex function in diverse cell activities, these results are not surprising.</p><disp-quote content-type="editor-comment"><p>2. Obtain additional insights into the mechanisms that contribute to the erythroid stage-specific effects. For example, Samd14 is significantly upregulated during stress erythropoiesis but CP expression is not affected. Is the Samd14-CP interaction via CPB dynamically regulated by stress erythropoiesis and/or by Kit signaling in a differentiation stage-specific manner?</p></disp-quote><p>We tested stress-specific, stage-specific and signal activation-dependent changes to the interaction between Samd14 and Capzb by endogenous Co-immunoprecipitation. Comparing WT Lin- spleen cells from control vs. PHZ-treated mice, we detected a 1.7-fold increase in Capzb pulled down. These results indicate that either the frequency or the affinity of the Samd14-CP interaction increased in anemia. To test whether the Samd14-CP interaction changes in distinct stages of erythropoiesis, we sorted CD71+Ter119- cells and CD71+Ter119+ cells and conduced IP analyses. In both R2 (CD71med/+Ter119-) and R3 (CD71+Ter119+) cells, Samd14 and Capzb were immunoprecipitated at similar ratios, indicating that the Samd14-CP interaction is not regulated in a stage-specific manner. To test the potential contribution of Kit pathway activation on the Samd14-CP interaction, Lin- cells were serum starved for 1 hour and then stimulated with SCF (10ng/mL) for 5 min. We compared the relative amount of protein immunoprecipitated by semiquantitative densitometry (N=3) which indicated there was no apparent change in the Samd14-CP interaction affinity after pathway activation. Collectively, these results suggest that the affinity of the Samd14-CP interaction increased in stress erythropoiesis but is not dynamically-regulated by erythropoietic stage or activated by SCF stimulation.</p><disp-quote content-type="editor-comment"><p>3. Functional assays (colony forming ability, proliferation, etc) or alternate assessment of Kit/EPO signaling would help further support conclusions.</p></disp-quote><p>To independently assess Kit activation, we tested SCF/Kit signaling induction of <italic>Kit</italic> primary transcript RNA. We previously noted that SCF stimulation increases <italic>Kit</italic> transcript levels in control cells but not Samd14 knockdown cells (Hewitt et al., Mol Cell 2015). Serum starved cells expressing EV, Samd14 or S14-ΔCPB were stimulated with 10 ng/mL SCF for 1 hour. In Enh-/- cells expressing full length Samd14, <italic>Kit</italic> primary transcript levels increased modestly (1.4-fold) but significantly (p=0.02), whereas Kit primary transcript levels did not increase in control empty vector-infected cells or cells expressing S14-ΔCPB. This provides an alternative read-out that demonstrates the requirement of the CPB domain of Samd14 to promote Kit signaling in stress erythroid progenitors.</p><disp-quote content-type="editor-comment"><p>4. Apart from pAKT and pERK, it would be helpful to obtain additional mechanistic insights into how the Samd14-CP complex regulates Kit signaling. The authors should consider one or few of the suggested experiments such as the use of Kit expression cell line and the effects on gene expression with knockdown of the capping proteins,</p></disp-quote><p>This revision incorporates several of the suggested reviewer experiments which were not included in the original manuscript. We tested whether Capzb function was specific to stress erythroid progenitors, or may apply more broadly in hematopoiesis, by shRNA mediated knockdown of Capzb in primary isolations of mouse WT bone marrow. This data showed that, while Samd14 expression is required for stress erythropoiesis but dispensable for steady-state erythropoiesis, the role of Capzb is not limited to anemic stress. Knockdown impaired cell viability and increased differentiation in bone marrow as well as spleen erythroid progenitors. As suggested by one reviewer, we conducted functional colony formation assays on immunophenotypically-defined cell populations (Kit<sup>+</sup>CD71<sup>low/med/high</sup>) to correlate the unique signaling requirements of these cells with a progenitor phenotype. Populations were characterized by increasing fraction of Ter119+ cells dependent on CD71 levels. The highest number of CFU-E were in the CD71<sup>med</sup>Kit<sup>+</sup> population, a population that was both SCF-responsive and Samd14 sensitive in phospho-flow cytometry assays. CD71high cells, which were responsive to Epo but not SCF, contained the highest number of Ter119+ cells but fewer CFU-E.</p><disp-quote content-type="editor-comment"><p>5. Given the observation that BFU-Es are down, it would be helpful to determine whether the early Kit+Sca1+CD133+ progenitors are affected, for example the expansion of these cells in culture with knockdown of the capping complex.</p></disp-quote><p>To determine whether the numbers of early stress erythroid progenitors correspond to changes in BFU-E activity, we performed multiple flow cytometric analyses (with biological repeats) of splenic cells at different time points (days 0, 1, 2, and 3) in our ex vivo system. We were able to detect Kit+Sca1+CD133+ progenitors in control bone marrow and spleen. However, following PHZ treatment, uncultured and cultured cells from spleen exhibited considerable levels of autofluorescence (especially in the Sca1 channel) which obscured any potentially measurable differences in these cell numbers among experimental conditions. This observation had been previously observed in our hands and noted in Bennet et al., (<italic>Methods Mol Biol</italic> 2019). Importantly, all flow cytometry analyses in this study use single stain and fluorescence minus one (FMO) controls to set gates and we do not detect significant autofluorescence after staining with antibodies targeting other surface markers (CD71, Ter119, Kit) or intracellular proteins (Ki67, pAKT, pERK) used to gate out various erythroid populations in other experiments.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. The authors provided evidence that Capza/b knockdown largely phenocopies Samd14 deficiency in PHZ-induced erythroid stress. To provide additional evidence for the Samd14-CP complex interaction in stress erythropoiesis, it would be of interest to perform Capza/b knockdown in Samd14-Enhancer knockout cells. These studies may further reveal whether the CP complex regulates erythroid cell maturation in a Samd14-dependent manner.</p></disp-quote><p>As described in “essential revisions” we conducted these experiments and data is shown in Supplemental Figure 2</p><disp-quote content-type="editor-comment"><p>2. The model that Samd14-CP interaction regulates c-Kit but not Epo signaling is based mostly on genetic complementation assay with expression of WT or various Samd14 mutants, as well as the downstream effects on signaling cascades (i.e. phosphorylation of AKT and ERK1/2). While informative, it would be interesting to obtain further insights into the mechanisms that may contribute to the stage-specific effects. For example, Samd14 is significantly upregulated during stress erythropoiesis but CP expression is not affected. Is the Samd14-CP interaction via CPB dynamically regulated by stress erythropoiesis and/or by c-Kit signaling in a differentiation stage-specific manner?</p></disp-quote><p>As discussed in “essential revisions”, we conducted additional experiments to test stage-dependent, signal-dependent and stress-dependent changes to the Samd14-CP interaction. We affinity purified both HA-Samd14 (bait) observed that the affinity of the Samd14-CP interaction increased in stress erythropoiesis but is not dynamically regulated by erythropoietic stage or activated by SCF stimulation.</p><disp-quote content-type="editor-comment"><p>3. Given that the main findings were based on PHZ-mediated anemic stress, it would be helpful for the authors to further discuss their findings in the context of more physiologically relevant models of stress erythropoiesis and pathologic settings.</p></disp-quote><p>We added text to discussion (Page 22 line 502). “Importantly, while we used PHZ injection as a model for acute anemia, Samd14 expression is also elevated in clinically relevant anemia models induced by severe bleeding and erythroid radioprotection, suggesting that Samd14 mechanisms are not specific to this model.”</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>A few more granular comments for the authors:</p><p>It is not clear from the apoptosis analyses discussed in 238-246 if there was an overall increase in cell death, or only in early/ late apoptosis. Looking at the specific viability of the R2/R3 cells would help to understand if they are maturing at an increased rate, or if they are dying. Also, it's not clear from the data presented that the role of Capzb is limited to maintaining viability in context of anemic stress. Does KD of Capzb in non-stressed erythroblasts or cell lines (like G1E or CD34)+ lead to loss of viability?</p></disp-quote><p>As discussed in “essential revisions”, we quantitated viability of cells expressing shRNA against Capzb. This analysis revealed increased numbers of dead (DAPI+) cells at all stages of immunophenotypically defined erythroid cells. Moreover, we also looked at cells isolated from bone marrow, which indicated that Capzb function is not limited to stress erythroid precursor function, since knockdown also increased differentiation and decreased viability in these cells.</p><disp-quote content-type="editor-comment"><p>For the studies in Figure 5A, it is not clear what cell populations are being studied. Only a fairly narrow window of erythroblasts are typically positive for both Cd71 and kit (CFU-E and ProE), so it seems somewhat counterintuitive to parse this population further by CD71 level.</p></disp-quote><p>Prior studies (Flygare, Lodish. 2011, Li, Lodish 2019) describe a continuum from BFU-E to CFU-E using CD71 and Kit as cell surface markers, demonstrating that unique functional states, transcriptional profiles and responses to growth factor stimulation exist throughout this transition. To address this, the revision incorporated functional data highlighting distinctions in erythroid differentiation and colony forming potential between populations of cells in the CD71<sup>low/med/high</sup>. Confirming prior studies, the CD71<sup>med</sup>Kit<sup>+</sup> population contained a higher fraction of CFU-E compared to CD71<sup>high</sup>Kit<sup>+</sup> cells.</p><disp-quote content-type="editor-comment"><p>shRNA can have off target effects in erythroid cells. Use of alternate methods such as TALENs or CRISPR/Cas9 to disrupt Capzb would further support the conclusions that the CP complex has a role in erythropoiesis.</p><p>It is interesting that the CP components are downregulated following anemic stress, while SAMD14 goes up. How do these expression changes fit into the model of SAMD14-CP interaction in stress erythroid progenitors? Did this change occur on the protein level as well?</p></disp-quote><p>While we did not conduct knockout experiments in cells, it is notable that knockdown data is consistent with functional comparisons of full length Samd14 compared to S14-ΔCPB. For example, colony formation is decreased in Capzb knockdown and in comparisons between expression of Samd14 and S14ΔCPB. Knockout experiments would potentially reveal new information, but Capzb knockout may be lethal to cells due the role of barbed end capping in diverse cellular processes (Gerdin et al., Acta Ophthalmologica. 2010). We conducted additional experiments in the revision which confirm that protein levels of Capzb were decreased similarly to mRNA in PHZ-treated spleen. Nothing is currently known about what regulates Capzb expression, but it is expressed at a high level in many cell types. While it is decreasing in anemic stress, the protein remains easily detectable in lin<sup>-</sup> cells.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The paper from Ray et al., does an excellent job of identifying new components of the Kit/SCF signaling pathway. The authors have built on previous data showing the Samd14 plays a key role in regulating increased activation of Erk and Akt signaling pathways downstream of Kit receptor during stress erythropoiesis. The CP complex was not previously identified as a component of this pathway. The biochemical analysis is a strength. The weaknesses of the paper have more to do with the phenotypic analysis. The paper does not extend the Samd14 findings that Erk and Akt signaling is affected. It would be greatly improved, if there were mechanistic data showing how the Samd14-CP complex interaction affected Kit signaling. The second weakness is in the analysis of stress erythropoiesis. The data from Samd14 and the knockdown of Capz show a defect in BFU-E. However, the analysis focuses on later stage cells and on cells isolated from spleens after the expansion of the stress BFU-E population has occurred. Furthermore, stress BFU-E respond to different conditions (Epo + BMP4 + SCF at 1% O2) than steady state BFU-E (Epo + IL-3 or SCF), the conditions used here were for steady state BFU-E so some aspects of the role of the CP complex in stress erythropoiesis may be lost. The discussion would also be improved if the role of Samd14/CP complex was put into the developmental context of stress erythropoiesis. The fact that you have fewer BFU-E and when you look at erythroblasts in your cultures, they skew towards more mature cells suggests the defect is in the proliferation of immature cells and the ability of these cells to resist differentiation.</p></disp-quote><p>We provide a figure illustrating that Sca1+CD133+Kit+ cells isolated from PHZ-treated spleen include a high degree of autofluorescence, particularly with Sca1 (multiple fluorophores obtained the same result). We do not think that reliable detection of this population from PHZ-treated spleen by flow cytometry is possible.</p></body></sub-article></article>